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Summary 
 
he  elucidation  of  the  molecular 
mechanisms  by  which  cells  respond  to 
insufficient  oxygen  supply  (herein  after 
referred  to  as  “hypoxia”)  is  central  to  our 
understanding  of many medical  processes  in 
health  and  disease.  During  embryonic  de‐
velopment,  adaptation  to  high‐altitudes  but 
also  in wound healing and  inflammation,  the 
cellular  oxygen  sensing  pathways  allow 
tissues  to appropriately adapt  their metabolic 
requirements  to  an  altered  oxygen 
environment.  Exhausted  capacities  of  these 
coping  strategies  ultimately  accumulate  in 
irreversible  tissue  demise  as  observed  in 
ischemic  diseases  such  as  infarction  and 
stroke.  The  very  same  signalling  structures, 
however, are frequently activated in cancerous 
lesions,  supporting  an  anaerobic  hyper‐
metabolic phenotype of the corrupted cells.  
Hypoxia‐inducible transcription factors (HIFs) 
have  been  identified  as  master  regulators  of 
the  hypoxic  response,  directly  activating  the 
expression  of  a  diverse  set  of  effector  genes 
involved  in  anticipatory  metabolic  changes, 
adaptive survival, or programmed death of the 
affected  tissue. HIFs  are  heterodimeric  trans‐
cription  factors  composed  of  oxygen‐labile 
α‐subunits  and  constitutively  expressed  HIF 
β‐subunits, originally identified as aryl hydro‐
carbon  receptor  nuclear  translocator  (ARNT). 
Stability of HIF‐α is regulated by a proteolytic 
step requiring post‐translational hydroxylation 
at two distinct proline residues situated in the 
so‐called  oxygen‐dependent  degradation 
(ODD)  domain.  The  actual  O2‐sensing 
molecules  in  this  process  are  the  recently 
identified  HIF  prolyl‐4‐hydroxylases,  alter‐
natively  termed  prolyl‐4‐hydroxylase  domain 
(PHD), HIF prolyl hydroxylase  (HPH) or  egg 
laying defective nine homolog  (EGLN).  In  an 
archaic,  yet  fascinatingly  effective  reaction, 
PHDs catalyze the transfer of an oxygen atom 
derived  from molecular O2  to  proline  402  or 
proline  564  of  human  HIF‐1α,  thereby 
providing a recognition  interface allowing the 
von Hippel‐Lindau  (pVHL)  tumor suppressor 
to  bind  and  initiate  poly‐ubiquitination  and 
proteasomal degradation. Facilitating a similar 
reaction,  factor  inhibiting  HIF  (FIH) 
hydroxylates a C‐terminal asparaginyl residue 
within HIF‐α subunits,  thereby regulating  the 
transcriptional activity of HIFs.  
My personal  interest  in  the  emerging  field of 
oxygen  sensing  focused  on  the  molecular 
understanding  of  integrational  sites  of  the 
complex  HIF‐pathway,  where  a  variety  of 
certain  upstream  effector‐pathways  are 
translated  into  a  single  action.  This  work 
summarizes  four  publications  built  on  each 
other where  I  contributed  as  (co‐)first  or  last 
author,  broadening  our  understanding  of  the 
fundamental  role  of  PHD  oxygen  sensor 
proteins  as  integral  regulators  of  oxygen‐
sensitive pathways within cells. 
 
A  single  promoter‐embedded  HIF‐binding 
site  confers  hypoxic  inducibility  to  human 
PHD2  
When HIF prolyl‐4‐hydroxylases were  identi‐
fied as  the molecular oxygen  sensors  in 2001, 
two  out  of  the  three members  encompassing 
family  have  been  shown  to  be  oxygen 
regulated.  Working  together  with  Prof. 
Metzen  (Essen, Germany), we characterized a 
functional hypoxia response element (HRE) in 
the  promoter  of  the  human  PHD2  gene, 
providing  experimental  evidence  that  PHD2 
can  be  classified  as  a  direct HIF  target  gene. 
Approaching  a  cloning  strategy  utilizing  a 
bacterial  artificial  chromosome  image  clone, 
we were  the  first  to succeed  in cloning of  the 
upstream  regulatory  region  of  the  human 
PHD2 gene.  Subsequent studies of this region 
in luciferase reporter gene assays revealed that 
a  CpG‐rich  promoter  element  in  close 
proximity  to  the  translational  start  site of  the 
gene  was  sufficient  for  basal  and  hypoxia‐
inducible  PHD2  transcription.  A  putative 
consensus  5’‐ACGTG‐‘3  HIF‐1  binding  site 
conserved  amongst  humans  and  mice  was 
identified by bioinformatic  sequence analysis. 
Functional recruitment of HIF‐1  to  this region 
was  further  demonstrated  by  gel  shift 
experiments  and  site‐directed mutagenesis  of 
the  respective  site  in  promoter  reporter 
contructs.  
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PHD  and  HIF  proteins  trigger  a  feedback 
loop  facilitating  adaptive  oxygen  sensing 
Under hypoxic  conditions  the  co‐substrate O2 
becomes  limiting  for  PHD  enzymes  and 
prolyl‐4‐hydroxylation  ceases,  dramatically 
increasing the protein half‐life of HIF‐α. Initial 
reports  emphasized  a  dominating  role  for 
PHD2  in setting  the normoxic  levels of HIF‐α 
and  more  recently  embryonic  lethality  of 
PHD2,  but  not  PHD3  and  PHD1  knock‐out 
mice  confirmed  this  prominent  function  of 
PHD2.  In  consideration  of  the  striking width 
of  tissue  pO2  values  found  in  healthy 
organisms  even  when  the  inspiratory  pO2  is 
considered  to  be  “normoxic”  (oxygen  partial 
pressures may range from ~100 mm Hg in the 
lung  alveolar  cells  to  <1 mm Hg  in  avascular 
cartilage  tissue),  it appeared enigmatic  from a 
Physiologist’s view, how a rather simple post‐
translational  enzymatic  modification  could 
comply with  such different  requirements and 
function  as unique molecular oxygen  sensing 
mechanism. 
Puzzled  by  this  problem,  my  more  recent 
work  could  demonstrate  that  hypoxically 
induced  HIF  prolyl‐4‐hydroxylases  are  well 
capable  of  functionally  regulating  HIF‐α 
subunits  even  under  limited  oxygen 
conditions.  Given  the  opportunity  of  latest 
generations’  oxygen‐controlled  incubators  to 
handle  and  even  split  cell  cultures  without 
perturbation  of  the  external  oxygen 
concentration, we were able  to grow  cells  for 
extended periods at 1% oxygen. Using such a 
model system, we showed in a broad range of 
cell  lines  that  HIF‐1  activation  indeed  is  a 
transient event and cells are capable  to adapt 
to a given oxygen  threshold by  increasing  the 
hydroxylation  capacity of  the oxygen  sensors 
PHD2  and  PHD3,  thus  establishing  a  new 
base‐line, “steady state” activation of the HIF‐
PHD  sensory  circuit.  Such  a  self‐regulatory 
gene‐effector  circuit  offers  an  appealing 
model,  how  cellular  oxygen  sensing  is 
generically  functional  throughout  the  whole 
organism in multicellular life. Obviously, PHD 
oxygen  sensors  need  to  operate  at  different 
pO2  setpoint  values  ‐  in  different  tissues  as 
well  as  in  variable  environments  e.g.  when 
under water  or  at  high  altitude.  Since  PHDs 
are  non‐equilibrium  enzymes  and  to  date  no 
antagonizing dehydroxylation  event has been 
identified,  cellular abundance of  the enzymes 
must  be  considered  as  a  rate  limiting 
parameter  of  the HIF‐hydroxylation  reaction. 
In keeping with one pre‐requisite for a rapidly 
tunable system, we could show that PHDs are 
not  abundant  within  cells  but  a  rather  fine 
balance between HIF‐α production and PHD‐
dependent degradation is kept: If either one is 
upregulated,  it overcomes  the  function of  the 
other.  Thus,  as  well  as  oxygen  availability 
limits the activity of PHD sensors, an increase 
in PHD synthesis  leads  to HIF‐α degradation. 
Likewise,  upregulated  HIF‐α  synthesis  will 
temporarily  exceed  the  preset  hydroxylation 
capacity  of  a  cell,  ultimately  leading  to  its 
stabilization  even  under  oxic  conditions.  If 
tissue  oxygenation  is  constant,  the  definition 
of a  setpoint  for oxygen  sensing by adjusting 
the HIF/PHD ratio will keep the system tuned 
and  allow  a  secondary  response  to  a  further, 
more severe hypoxic insult. 
 
A  reconstituted  in  vitro  system  as  a  tool  to 
study PHD dependent HIF‐α hydroxylation 
PHDs  belong  to  the  superfamily  of  2‐
oxoglutarate  (2‐OG)  and  Fe(II)‐dependent  di‐
oxygenases  catalysing  the  oxidative  de–
carboxylation  of  2‐OG  to  succinate  by 
releasing  gaseous  CO2.  In  support  with  a 
classical model of product inhibition, succinate 
(and  other  Krebs  cycle  intermediates)  have 
been  reported  to  interfere  with  PHD 
hydroxylation  activity,  providing  a  possible 
link  between  mitochondrial  respiration  and 
cellular oxygen sensing pathways. Likewise, a 
variety  of  bi‐valent  transition  metal  ions, 
known  since  the  early  days  of  hypoxia 
research  to  phenocopy  cellular  responses  to 
oxygen  deprivation,  have  been  suggested  to 
exert  their  “hypoxia  mimicking”  effects  via 
interference with HIF‐hydroxylating PHDs. In 
order  to  systematically  study  the  effects  of 
putative  PHD–inhibitory  and  ‐activating 
compounds,  a  reconstituted  in  vitro  hydroxy‐
lation assay was adapted to our needs. In brief, 
this  assay  utilizes  recombinant  PHDs  as 
enzyme  source  to  hydroxylate  a  synthetic, 
biotinylated  peptide  derived  from  human 
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HIF‐1α  coupled  to  strepavidin‐coated  96‐well 
plates. The fraction of hydroxylated peptide is 
subsequently  quantified  by  enzyme‐linked 
immunosorbent  detection  of  bound  recom‐
binant pVHL in complex with Elongins B and 
C. As full length PHD enzymes expressed and 
purified  from  bacterial  cultures  happened  to 
maintain  poor  enzymatic  activity,  we 
established  an  insect‐cell  based  recombinant 
expression  system  for  all  isoforms  of  PHDs. 
We  could  show,  that  all  three PHDs purified 
close  to  homogeneity  were  similarly  depen‐
dent  on  addition  of  exogenous  ferrous  iron 
and  reduced  vitamin  C  (ascorbate)  in  the 
micromolar  range  to  allow  efficient  in  vitro 
hydroxylation  of  HIF‐α  peptides.  Moreover, 
N‐acetyl‐L‐cystein  was  unable  to  replace 
ascorbate  in  this  in  vitro  reaction  and  some 
antioxidants  even  inhibited  HIF‐α  hydroxy‐
lation  (as  the polyphenolic compounds  found 
in green  tea). Yet, a more  specific  function of 
ascorbate  in  supporting  PHD  activity  than 
simply providing antioxidative moieties has to 
be  considered.  Underlining  its  important 
function in vitro, our data further revealed that 
metal‐catalyzed oxidation of vitamin C (e.g. by 
cupric  copper)  completely  abolished  PHD 
function, providing a plausible mechanism for 
the  HIF‐stabilizing  effects  of  at  least  some 
transition metals. 
 
Cellular  oxygen  sensing  is  not  affected  by 
nutritional vitamin C deficiency  
It was broadly accepted that HIF‐hydroxylases 
are vitamin C dependent enzymes, a view that 
is supported by  the requirement of vitamin C 
for sufficient  in vitro hydroxylation activity of 
PHDs  as  observed  by  several  groups, 
including ours. Given the close relationship of 
PHDs  to  collagen  prolyl‐4‐hydroxylases  (C‐
P4H),  where  a  clear  link  between  systemic 
vitamin C deficiency,  reduced C‐P4H activity 
and  the  collagen  disassembly‐disease  scurvy 
(lat.  scorbutus)  is well  known, we  speculated 
that  PHDs  might  likewise  be  affected  by 
vitamin C abundance in vivo. This assumption 
was  further  supported  by  the  relatively  high 
Km values for both, PHDs and C‐P4H, ranging 
between  140  and  300 μM  ascorbate,  respect‐
tively.  Of  note,  human  cells  in  culture  have 
much  lower  intracellular  ascorbate  concen‐
trations  (1‐50 μM)  than  these Km  values,  and 
plasma levels of vitamin C in humans are in a 
similar range. 
To  our  surprise,  a  fully  functional  oxygen 
sensing pathway was found in cells adapted to 
grow  in  the  complete  absence  of  vitamin  C. 
Supporting these data, we found no significant 
differences  in  the  systemic  response  to 
inspiratory  hypoxia  between  control  and 
scorbutic  animals  of  a  genetically  modified 
mouse  strain  resembling  the pathophysiology 
of  scurvy.  In  parallel  studies  using  our 
hydroxylation  assay  platform  we  had 
identified  glutathione  (GSH)  as  a  strikingly 
potent  activator  of  PHD  enzymes  with  the 
abilities  to  fully  substitute  ascorbate  in  the 
hydroxylation  reaction  in  vitro.  Thus,  this 
highly  abundant  intracellular  antioxidant 
might have compensated the lack of ascorbate 
as  a  co‐factor  for PHDs  in  our  in  vivo model 
systems. Indeed we could show, that GSH and 
ascorbate were  similarly  functional  to  reduce 
HIF‐1α  accumulation  in  response  to  the 
hypoxia‐mimetic  cobalt  chloride  in  human 
hepatoma  cultures  (though  both  of  the 
antioxidants  failed  to  impair  hypoxic HIF‐1α 
induction).  As  hypoxia‐mimetics  unphysio‐
logically  activate  the  HIF  pathway  at  oxic 
conditions, we  further  tested  the  influence of 
oxidative stress to the PHD enzymes itself.   A 
profound  reduction  of  protein  carbonylation 
was  noted  when  GSH  was  present  in  the 
hydroxylation  reaction,  suggesting  that 
oxidative  damage  to  the  enzyme  during 
hydroxylation  reaction  might  well  affect  the 
activity  of  PHDs. Wether  such  a model  also 
applies  to  HIF‐α  hydroxylation  by  PHDs  in 
situ, where the intracellular environment must 
be  considered  as  strongly  reducing,  requires 
further  work.  In  summary,  our  work  could 
clearly show that vitamin C is not an essential 
co‐factor  for  HIF‐α  hydroxylation  by  PHD 
enzymes  in vivo, challenging  the current view 
of PHDs as vitamin C requiring enzymes. 
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Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene:
identification of a functional hypoxia-responsive element
Eric METZEN1,2, Daniel P. STIEHL1, Kathrin DOEGE, Jan H. MARXSEN, Thomas HELLWIG-BU¨RGEL and Wolfgang JELKMANN
Institute of Physiology, University of Luebeck, Ratzeburger Allee 160, D23538 Luebeck, Germany
The HIFs (hypoxia-inducible factors) are a family of heterodi-
meric transcription factors essential for the adaptation of cells to
reduced oxygen supply. Three human PHDs (prolyl hydroxylase
domain proteins, PHD1–PHD3) initiate oxygen-dependent de-
gradation of HIF-α-subunits in normoxia. RNA interference
directed against PHD2, but not PHD1 or PHD3, is sufficient to
stabilize HIF-1α in normoxia. Therefore PHD2 is regarded as
the main cellular oxygen sensor. PHD2 itself is up-regulated by
hypoxia and may thus limit hypoxic signalling. By sequence ana-
lysis, we predicted a promoter approx. 3.5 kb 5′ of the translation
start codon and a second promoter located in a CpG island im-
mediately upstream of the coding sequence. A consensus HIF-1-
binding site that is conserved in the murine phd2 gene was
detected in the CpG island. By electrophoretic mobility-shift
assay, we demonstrated binding of HIF-1 to the putative HIF-1-
binding site. In luciferase reporter vectors, the isolated upstream
promoter was inactive in all cell lines tested unless 200 bp were
deleted at the 3′-end. The downstream promoter was active and
induced by hypoxia. In reporter vectors containing both promoter
sequences, luciferase activity was equal to vectors containing
only the downstream promoter. In cells transfected with a vector
containing both promoters, a single luciferase transcript was de-
tectable. This transcript had the same length as transcripts from
a vector containing the downstream promoter only. We conclude
that the phd2 gene is transcribed exclusively from the downstream
promoter that contains a functional hypoxia-responsive, cis-regu-
latory element. Our results establish that PHD2 is a direct HIF
target gene.
Key words: egg-laying deficiency protein nine-like protein
(EGLN), hydroxylation, hypoxia, hypoxia-inducible factor (HIF),
oxygen, prolyl hydroxylase domain (PHD).
INTRODUCTION
HIF (hypoxia-inducible factor) is a transcription factor central to
a large number of adaptive processes in a situation of reduced
oxygen supply. Hypoxia is a feature of cardiovascular diseases
associated with ischaemia and also plays an important role in
tumour biology. Therefore HIF is currently regarded as an attrac-
tive target in the development of new therapeutic strategies (see
[1–3] for reviews).
HIF is composed of an oxygen-sensitive α- and a constitutive
β-subunit that is also known as arylhydrocarbon receptor nuclear
translocator. Three related α-subunit paralogues have been char-
acterized. For example HIF boosts red blood cell production by
the induction of erythropoietin, and enhances transcription of an-
giogenic factors, e.g. vascular endothelial growth factor. Further-
more, HIF induces glucose transporters as well as virtually all
glycolytic enzymes and thus favours anaerobic cell metabolism.
More than 50 genes have been found to be HIF responsive (see
[4] for a review). Inducibility by HIF is linked to the presence of a
core HIF binding consensus sequence (ACGTG) in regulatory re-
gions of HIF target genes. The most prominent example of a
HIF binding HRE (hypoxia-responsive element) is the enhancer
located 3′ to the epo gene that enabled the identification of HIF-1
[5,6].
The α-subunit of the active transcription factor HIF-1 is nor-
mally undetectable in the presence of oxygen whereas it becomes
stable in hypoxia. The degradation process is triggered in nor-
moxia by enzymatic hydroxylation of two conserved proline
residues (Pro-402 and Pro-564 in human HIF-1α, [7–9]). Only
hydroxylated HIF-α binds the pVHL (von Hippel–Lindau protein)
that is part of an E3 ubiquitin ligase. After ubiquitination, HIF-α
molecules are rapidly degraded by the proteasome [10,11]. A se-
cond control mechanism is the hydroxylation of Asn-803 in the
C-terminal transactivation domain by the enzyme FIH-1 (factor
inhibiting HIF-1) [12–14] that prevents the recruitment of tran-
scriptional co-activator proteins.
The four human HIF-α hydroxylases that have been character-
ized so far (PHD1–PHD3 and FIH-1, where PHD stands for a
prolyl hydroxylase domain protein) belong to a family of 2-oxo-
glutarate-dependent, non-haem iron-binding dioxygenases [15–
17]. PHD1, PHD2 and PHD3 have also been termed HPH3,
HPH2 and HPH1 [16], and EGLN2, EGLN1 and EGLN3 [18].
No substrates other than HIF-α have been reported to date. The
PHDs are widely expressed in tissues [19,20]. PHD homologues,
as well as HIF homologues, have been identified in all multi-
cellular organisms investigated so far, termed EGL-9 (egg-laying
deficiency protein 9) in Caenorhabditis elegans [15], CG1114 in
Drosophila melanogaster [21] and SM-20 in rat [22]. In mouse,
three PHDs with similarity to the human enzymes have been found
by database analysis [18].
Notably, PHD2 inhibition by RNAi (RNA interference), but not
inhibition of PHD1 or PHD3, is sufficient to up-regulate HIF-1α
in normoxia, indicating that the three enzymes are not simply
redundant [23] and that PHD2 may be the main cellular oxygen
sensor. PHD2 and PHD3 have been reported to be hypoxia-
inducible [15,23,24]. Dysregulation of HIF-α in pVHL-deficient
Abbreviations used: EGLN, egg-laying deficiency protein nine-like protein; EMSA, electrophoretic mobility-shift assay; EST, expressed sequence tag;
FIH, factor inhibiting HIF-1; HIF, hypoxia-inducible factor; HBS, HIF-1-binding site; HRE, hypoxia-responsive element; MEF, mouse embryonic fibroblasts;
PHD, prolyl hydroxylase domain protein; pVHL, von Hippel–Lindau protein; RNAi, RNA interference; UTR, untranslated region; wt, wild-type.
1 These authors have contributed equally to this work.
2 To whom correspondence should be addressed (email metzen@physio.uni-luebeck.de).
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renal clear cell carcinoma cells is associated with the loss
of hypoxic PHD2 and PHD3 induction [25], and the inhibition of
HIF-α by RNAi also leads to a loss of induction of PHD2 and
PHD3 in hypoxia [26]. These results suggest that HIF itself may
mediate the induction and that HIF and PHDs form a feedback
loop that limits hypoxic signalling and accelerates HIF degrad-
ation after reoxygenation. However, HIF-responsive elements in
control of the phd2 gene have not been identified yet.
In the present study, we demonstrate that a promoter element
located in a CpG island approx. 0.5 kb upstream of the translation
start site of the phd2 gene is dominant in all cell lines tested.
This promoter contains a HBS (HIF-1-binding site) that is the cis-
acting regulatory element causing induction of the human phd2
gene by hypoxia. Thus our results prove that PHD2 is a direct HIF
target gene.
MATERIALS AND METHODS
Computational sequence analysis
Promoter region prediction and analysis of transcription factor
binding sites in relevant parts of human and murine genes for
PHD2 were performed with the GenomatixSuite software (Geno-
matix Software GmbH, Munich, Germany). Sequence alignments
were performed with the tools of ClustalX program [27]. CpG
islands within the genes of human and murine phd2 were identi-
fied by means of the CpG-island-extraction algorithm as de-
scribed previously [28]. The CpG island searcher is available at
http://www.uscnorris.com/cpgislands/cpg.cgi. EST (expressed se-
quence tag) searching was performed using the Gene2EST
BLAST server available at http://zurg.embl-heidelberg.de/
Cell culture
Human hepatoma cells HepG2, human ovarial carcinoma cells
OVCAR3 and osteosarcoma cells U2OS were cultured in
Dulbecco’s modified Eagle’s medium (Gibco, Karlsruhe,
Germany) supplemented with 10% (v/v) foetal calf serum
(Gibco), 2 mM glutamine (Gibco), 50 units/ml penicillin and
50 µg/ml streptomycin (Sigma, Deisenhofen, Germany). Normal
MEF+/+ (mouse embryonic fibroblasts) and the same cells bearing
an inactivation of the hif-1α gene (MEF−/−) were engineered by
R. S. Johnson (Division of Biological Sciences, University of
California at San Diego, La Jolla, CA, U.S.A.) and provided
by R. H. Wenger (Institute of Physiology, University of Zu¨rich,
Zurich, Switzerland). MEFs were cultured in the same media
as the human cells. Hypoxic incubations were performed either
in an oxygen-regulated cell culture incubator (Heraeus, Hanau,
Germany) or in an InvivO2 400 hypoxia workstation (Ruskinn
Technologies, Leeds, U.K.).
Nuclear extract preparation and EMSA (electrophoretic
mobility-shift assay)
Nuclear extracts were prepared from HepG2 cells incubated in a
3% oxygen atmosphere for 4 h as described earlier [29]. Oligonu-
cleotides for gel-shift assays were synthesized by MWG-Biotech
(Ebersberg, Germany). Sequences were derived from the human
phd2 gene, containing the putative HBS (PHD2-HBS, nt 2747,
GenBank® accession no. AF229245) or a mutated HBS (PHD2-
HBSmut). Sequences for wt (wild-type) and mutant oligonucleo-
tides were as depicted in Figure 1(A). As positive control, an oligo-
nucleotide containing the HIF-1 responsive element (containing
two HBSs) from the human transferrin gene (TfHBS) was used
as described in [30]. The 5′-end labelling, annealing and binding
reactions were performed as described previously [29]. Samples
were resolved by electrophoresis on native 5% polyacrylamide
gels at room temperature (20 ◦C). Gels were dried and analysed by
phosphoimaging (BAS 1000; Fuji, Du¨sseldorf, Germany). Speci-
ficity was tested by supershift experiments. For this purpose, 1 µl
of undiluted monoclonal anti-HIF-1α antibody (BD Biosciences,
Heidelberg, Germany) was added 60 min before the gel was run.
Quantitative PCR
Mouse embryonic fibroblasts were incubated in an atmosphere of
1% oxygen for 4 h. Total RNA was isolated following a standard
method [31]. RNA (1 µg) was reverse transcribed with oligo-
(dT) and Transcriptor Reverse Transcriptase (Roche, Penzberg,
Germany). The coding sequence of mouse PHD2 was assembled
from ESTs published previously [18]. Primer sequences were:
(forward) 5′-GACCGGCGTAACCCTCATG-3′ and (reverse)
5′-TTGCTGACTGAATTGGGCTTG-3′. Mouse PHD2 mRNA
expression was quantified using the qPCR Mastermix for SYBR
Green I (Eurogentech, Seraing, Belgium) and the ABI Prism 7000
Sequence Detection System (Applied Biosystems, Foster City,
CA, U.S.A.). Murine ribosomal L28 was used as a housekeeping
gene. PCRs were set up in a final volume of 25 µl and contained
2 µl cDNA, 1× reaction buffer with SYBR Green I and 20 pmol
of each forward and reverse primer. PCR conditions were set to
10 min at 95 ◦C followed by 40 PCR cycles (15 s at 95 ◦C and
1 min at 60 ◦C). Amplification of one specific PCR product was
confirmed by melting-point analysis. Data were analysed using
the delta-delta Ct method (where Ct stands for cycle threshold).
Plasmid construction
Fragments of the phd2 gene used in this study were amplified by
PCR using DNA isolated from bacterial artificial chromosome
clone RP11-295G20 (GenBank® accession no. AL445524;
Wellcome Trust Sanger Institute, Hinxton, U.K.) provided
by RZPD Deutsches Ressourcenzentrum fu¨r Genomforschung
GmbH (Berlin, Germany). Luciferase reporter gene constructs
were obtained by cloning the region of interest into the pGL3-
family of vectors (Promega/Boehringer Ingelheim, Heidelberg,
Germany). Mutations of the HBS plasmids were produced by site-
directed mutagenesis utilizing the oligonucleotide primers PHD2-
HBSmut (sense) and PHD2-HBSmut (antisense) that had also
been used for EMSA. Since the HBS is located in a CpG-rich re-
gion, mutagenesis PCR was performed with Thermal Ace® poly-
merase (Invitrogen, Karlsruhe, Germany) for amplification of GC-
rich templates according to the manufacturer’s instructions. The
numbering of all plasmids is according to the mRNA registration
by Dupuy et al. (GenBank® accession no. AF229245) [33]. All
plasmids containing PCR-inserts or mutations respectively were
sequence-verified (Seqlab, Goettingen, Germany).
In detail, the following plasmids were constructed: for the sub-
set of 5′-promoter reporter vectors, a region of −1535 to +1
flanked XhoI and HindIII was cloned into pGL3-basic. This se-
quence contains an internal HindIII site. Thus incomplete diges-
tion with HindIII resulted in pGL3b(−1535/1)P2P and pGl3b-
(−1535/−191)P2P. A SacI–XhoI PCR-fragment spanning nt
−985 to +137 was ligated into pGL3-basic and was named
pGL3b(−985/137)P2P. For pGl3b(1454/3172)P2P-wt, the de-
signated PCR product flanked XhoI and HindIII was amplified
and ligated into pGL3-basic. The corresponding plasmid pGl3b-
(1454/3172)P2P-mt containing the mutation of the HBS was
generated as described above.
Reporter constructs possessing the two putative regulatory re-
gions in the endogenous context [pGL3b(−1535/3172)P2P-wt
and pGL3b(−1535/3172)P2P-mt respectively] were derived by a
two-step cloning strategy. A XhoI–BamHI flanked PCR-product
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Figure 1 HIF-dependence of PHD2 expression
(A) The phd2/egln-1 gene in human and murine genome. Although in mouse the analysis of nucleotide sequences recognizes a single promoter located in a CpG island closely upstream of the
translational start site, analysis of the human gene leads to prediction of one promoter 3.5 kb upstream of the translational start site and an alternative promoter in a CpG island approx. 0.5 kb 5′ of
the translational start site. The HBS is conserved between species. (B) PHD2 expression in mouse embryonic fibroblasts containing wt (HIF+/+) or inactivated (HIF−/−) hif-1α gene. The cells were
incubated in normoxia (20 % O2) or hypoxia (1 % O2). Total mRNA was subjected to reverse transcription and quantitative PCR. Relative amount of PHD2 cDNA was calculated by the delta-delta
Ct method. Individual PHD2-Ct values were normalized to corresponding L28 Ct-values. Normalized PHD2 values were set in relation to the mean of the HIF+/+ normoxia group. (C) EMSAs with
nuclear extracts from HepG2 cells. Cells were incubated at 20 or 3 % oxygen for 4 h. Oligonucleotides used were: PHD2-HBSmut (mutated HBS, negative control), PHD2-HBS-wt (putative HBS) and
Tf-HBS (positive control). Specificity of the HIF-1 signal was demonstrated by supershift analysis with an anti-HIF-1α antibody. HIF-1, specific signal; const., constitutive DNA-binding; non spec.,
non-specific DNA-binding. All samples were run on the same gel. The Tf-HBS part of the image was electronically brightened.
corresponding to (−1535/1454) was ligated into pGL3-basic
utilizing an internal BamHI site at 1454 of the phd2 gene. Sub-
sequently, a cassette containing (1454/3172) and the luc gene was
released with BamHI from pGL3b(1454/3172)P2P-mt and cloned
into the intermediate to gain the full-length vector. The cor-
responding wt was obtained by replacing an endogenous SfiI
fragment including the wt HRE derived from SfiI-digested
pGl3b(1454/3172)P2P-wt.
Reporter gene plasmids carrying the HRE-regulatory region in
trans-position, i.e. downstream of an SV40 promoted luciferase
gene, were derived by a recombinant cloning strategy. An internal
BamHI site in position 1454 was used to release a BamHI–XhoI
fragment of pGl3b(1069/3172)P2P-wt and of pGl3b(1069/3172)-
P2P-mt and ligated into pGL3-prom opened with BamHI–SalI.
The resulting plasmids were termed pGl3-prom-3′E(1454/3172)-
P2P-wt and pGl3-prom-3′E(1454/3172)P2P-mt respectively. Pu-
rity and concentration of all plasmids transfected into cells was
estimated by agarose gel electrophoresis.
Transfection and luciferase assays
Transient transfections were performed on 100 mm dishes using
Fugene 6 (Roche Applied Science, Mannheim, Germany) trans-
fection reagent by following the manufacturer’s instructions. To
normalize for transfection efficiency, 3 µg of each reporter con-
struct was co-transfected with 1.5 µg of a cytomegalovirus-pro-
moter-driven β-GAL expression plasmid (a gift from P. J.
Ratcliffe, The Henry Wellcome Building of Genomic Medicine,
University of Oxford, Oxford, U.K.). Transfected cultures were
grown overnight, trypsinized the following day and split into two
equal parts and placed on two 6-well plates, i.e. from a single
transfected plate 12 separate cell culture wells were produced
which allowed the incubation of cells from the same transfection
either in normoxia or in hypoxia. Cells were allowed to become
adherent and subsequently incubated for 16 h either under nor-
moxic or hypoxic (1%O2) conditions. Cell lysates were prepared
with passive lysis buffer (Promega) and aliquots were assayed
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for luciferase expression with a Microlumat LB96P luminometer
(EG-G Berthold, Bad Wildbad, Germany). Additionally, β-GAL
expression for each sample was measured. Data are expressed in
relative light units (luciferase counts/β-GAL expression). Bars
indicate means +− S.D. for six separate cell culture wells. All
experiments were performed repeatedly so that all results were
confirmed in at least one completely independent experiment.
Transient transfections for subsequent luciferase Northern blot-
ting were performed following a similar transfection procedure.
Cells growing in 100 mm dishes were transfected with 3 µg of the
indicated reporter constructs. Plates were grown overnight and
divided equally on two 150 mm culture dishes. Corresponding
cultures were exposed to either normoxia or 1% oxygen for 16
additional hours, cells were then lysed and total RNA was isolated
as described above.
Northern blotting
Human osteosarcoma U2OS cells and human ovarial carcinoma
cells OVCAR3 were incubated in a normoxic (20% O2) or
hypoxic (1% O2) atmosphere for 4 h. Total RNA was isolated as
described above. mRNA was purified using 0.5 mg of total RNA
(Oligotex mRNA Midi; Qiagen, Hilden, Germany) following
the manufacturer’s instructions. mRNA (4 or 6 µg) of each sample
was subjected to electrophoresis in denaturing 1% agarose gels
containing 0.7 M formaldehyde. RNA transfer, prehybridizations
and hybridizations were performed exactly as described pre-
viously [29]. A hybridization probe was generated by restriction
digest of pcDNA3-PHD2 with NotI and EcoNI and thus contained
nt 3543–3800 (GenBank® accession no. AF229245). Ribosomal
protein L28 mRNA was used to confirm equal loading and transfer
as described previously [32]. The L28 hybridization probe was
amplified from HepG2 cDNA by PCR. For detection of luciferase
mRNA, 20 µg of total RNA was resolved on denaturing agarose
gels. The hybridization probe for luciferase mRNA was excised
from pGL3-basic using EcoNI and thus encompassed nt 646–1046
(GenBank® accession no. U47295). In this case equal loading was
verified by ethidium bromide staining of 28 and 18 S rRNA. All
probes were labelled using a commercial DNA labelling kit (MBI
Fermentas, St. Leon Rot, Germany). Filters were analysed by
phosphoimaging.
RESULTS
The prime objective of the present study was to identify the
HRE(s) conferring hypoxic induction of the phd2/egln-1 gene.
Interestingly, two GenBank® entries have been deposited
(GenBank® accession nos. AF229245 and AJ310543) that do not
differ regarding the coding sequence of PHD2. However, one of
these sequences contains an unusually large 5′-UTR (5′-untrans-
lated region) [33], which has been confirmed experimentally by
anchored PCR using an embryonic cDNA as template. The other
has been assembled from ESTs and has a short 5′-UTR but an
extended 3′-UTR [18].
To define regulatory sequences, we analysed genomic DNA
from approx. 8 kb upstream relative to the translation start site to
a region approx. 5 kb downstream of the human PHD2 coding se-
quence. Two putative promoter regions were predicted, one of
which contains a cellular TATA box and is located 3.5 kb upstream
of the translation start site, whereas the second promoter region is
contained in a CpG island 0.5 kb 5′ of the translation start codon.
Transcription factor binding analysis identified one HIF-binding
motive (ACGTG) located in the downstream promoter 412 bp
upstream of the start codon (Figure 1A).
Importantly, the potential HBS within the CpG island is con-
served in mouse phd2 sequence. In line with this computational
analysis, we show by comparison of mouse embryonic fibroblasts
carrying a null mutation for the HIF-1α gene with wt cells [34] that
the hypoxic induction of mouse phd2 expression is exclusively
dependent on the presence of HIF-1α (Figure 1B).
To demonstrate the functional importance of the putative HBS,
it was a prerequisite to prove binding of HIF-1α to the sequence
under investigation. In EMSAs, oligonucleotides derived from the
human phd2 sequence containing the wt HBS bound a protein
complex from hypoxic HepG2 cells which was supershifted on
the addition of a HIF-1α antibody (Figure 1C). Binding of HIF-1
was abolished by mutation of the HBS.
We went on to dissect the function of the two putative pro-
moters, to analyse their interplay, and their oxygen sensitivity by
means of luciferase reporter gene assays. The promoter regions
were cloned separately or in combination, 5′ to a promoterless
luciferase gene. The expression of the luciferase gene was ana-
lysed after normoxic and hypoxic incubation. In all cell lines
tested, the upstream promoter was inactive. In contrast, the down-
stream promoter was moderately active in normoxia but strikingly
induced by hypoxia (Figure 2A). In all cell lines, hypoxic induc-
tion was dependent on the presence of the HBS located in the
CpG island. We also used vectors that contained both putative
promoters and demonstrated that the activity of this construct was
essentially indistinguishable from constructs containing only the
downstream promoter region (Figure 2B). When we deleted
the terminal 200 bp of the upstream promoter it became active but
remained unresponsive to hypoxia (Figure 2C). This result may
indicate that the promoter region between −200 and +1 contains
a repressor element that blocks promoter activity in all cell lines
that we have analysed. To further delineate the properties of
the downstream promoter region, we produced a vector that
contained the luciferase gene driven by a heterologous SV40 pro-
moter followed by the regulatory sequence in a 3′ position. In
this experiment, the downstream sequence conferred hypoxic
inducibility on the SV40 promoter, i.e. the region under investi-
gation can, at least in this artificial reporter gene context, have
enhancer function (Figure 2D).
We have noted that independent groups have found two bands
by Northern blotting for PHD2 in human [33] and in murine
[20] tissues. These transcripts had a length of approx. 4 and 2 kb
respectively. Another report shows that three bands are detectable
[23], which is consistent with our own PHD2 Northern blot results
(Figure 3A). Interestingly, our experiments showed that all of
these bands were induced by hypoxia.
To determine whether transcripts are produced from the up-
stream promoter when it is not in isolation, we transfected cells
with luciferase vectors that contained both promoter regions or the
isolated downstream promoter and performed luciferase Northern
blotting. We detected a single transcript that had the same length
in all samples, indicating that all transcripts originated from the
downstream promoter (Figure 3B).
The activity of a single hypoxia-responsive promoter was in
harmony with the observation that all transcripts were hypoxia-
inducible, but it did not help to interpret the presence of three de-
tectable PHD2 transcripts by Northern blotting. Revisiting
the GenBank® entries AF229245 and AJ310543, we found that
three poly(A)+ (polyadenylated) signals have been reported which
are located 60, 500 and 2630 bp downstream of the translation stop
signal. The use of the downstream promoter together with these
alternative poly(A)+ signals is predicted to result in three tran-
scripts, which are approx. 1.9, 2.3 and 4.4 kb in length, which is
well in line with our Northern blotting results. To test this hypo-
thesis, we used U2OS mRNA samples for reverse transcription
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Figure 2 Luciferase reporter gene assays
The regulatory DNA regions of the human phd2 gene were cloned into luciferase reporter vectors, which were transiently transfected into cells. 24 h after transfection, cells were incubated overnight
under normoxia or hypoxia. β-galactosidase served as a transfection control. Bars represent means +− S.D. for six separate cell culture wells. (A) The function of the promoter located approx. 3.5 kb
upstream of the translational start site (PHD2 5′-prom) when compared with the downstream promoter region which contains either the wt HBS (wt) or a mutation of the HBS (mt) in U2OS, HepG2
and Hep3B cells. For example, a pGL3-basic vector that contains position −985 to position +137 of the putative regulatory region of PHD2 (numbering according to GenBank® accession no.
AF229246) is termed pGL3b(−985/137)P2P. (B) Luciferase expression was analysed in U2OS cells transfected with reporter vectors containing both regulatory regions or the isolated downstream
promoter element. (C) The isolated upstream promoter was compared with a truncated version of the same regulatory region. (D) The downstream promoter region in a position downstream of the
luciferase gene conferred hypoxic induction on an SV40 promoter, demonstrating enhancer activity of the region under investigation.
with oligo(dT) or specific oligonucleotides binding upstream of
the 3′ promoter. Although we could readily amplify PCR products
from the extended 3′-UTR, we were not able to generate PCR pro-
ducts from the region between the two promoters (results not
shown). These results suggest that indeed only the downstream
promoter is active in cells and that the different transcripts arise
from the use of distinct poly(A)+ signals.
DISCUSSION
The human HIF-α prolyl-4-hydroxylase PHD2 is of high biomedi-
cal relevance since it is the enzyme that down-regulates the oxy-
gen-sensitive transcription factor subunit HIF-α [23] in normoxia.
Besides the reports mentioned above further studies have demon-
strated the induction of PHD2 and of another HIF-prolyl-4-
hydroxylase (PHD3) by hypoxia in various cell lines and by use of
different experimental techniques [35–37]. It has also been shown
that dysregulation of HIF-1α is associated with the loss of hypoxic
induction of PHD2. Inactivation of pVHL, a protein necessary for
oxygen-dependent degradation of HIF-1α, leads to high normoxic
levels of HIF-1α and PHD2 [25]. RNAi directed against HIF-1α
has also been reported to eliminate hypoxic PHD2 induction [26].
These results suggest that PHD2 may be a target gene of HIF-1.
The evidence is, however, circumstantial. The classification of
PHD2 as a HIF target gene requires the experimental identification
of a cis-regulatory HRE in the phd2/egln-1 gene, which was the
aim of the present study. Importantly, presence of a consensus
HIF-binding motif in a regulatory DNA domain is not sufficient
to demonstrate hypoxic induction by HIF, as it has been shown that
erythroid 5-aminolevulinate synthase is hypoxia-inducible but
HIF-independent although a putative HBS is found in the pro-
moter of this gene [38].
c© 2005 Biochemical Society
716 E. Metzen and others
Figure 3 Analysis of PHD2 promoter function by Northern blotting
(A) PHD2 Northern blot. Human osteosarcoma (U2OS) and ovarian carcinoma (OVCAR3) cells
were subjected to normoxic (20 % O2) or hypoxic (1 % O2) incubation for 4 h. mRNA was
isolated as described in the Materials and methods section. mRNAs (4 µg U2OS or 6 µg
OVCAR3) were run in each lane. Hybridization probes corresponded to PHD2 nt 3543–3800,
GenBank® accession no. AF229245. The PHD2 transcripts are approx. 4.1, 2.3 and 1.8 kb.
The constitutively expressed ribosomal protein L28 was used as a loading and transfer control.
(B) Luciferase Northern blot U2OS cells were transfected as described in the Materials and
methods section. The cultures were subjected to normoxic or hypoxic incubation overnight.
Total RNA was isolated and 20 µg was resolved in each lane.
The phd2 gene has been localized as the 12th open reading
frame on chromosome 1 (C1ORF12) and is reported to contain
five exons [33]. According to the report, exon 1 includes 4047 bp
with the translational start site in position 3157, thus the initial
3156 bp are an unusually large 5′-UTR. Importantly, this 5′-UTR
has been verified experimentally by PCR walking and anchored
PCR using a random embryonic total cDNA library. Conse-
quently, the study implies that an active promoter is situated
upstream to the 5′-UTR. However, searching EST databases with
the 5168 bp PHD2 mRNA sequence (GenBank® accession no.
AF229245) results in retrieval of more than 300 ESTs none of
which contains a sequence upstream to the CpG island overlap-
ping the translation start site.
Presence of a CpG island spanning the terminal region of the
5′-UTR and the beginning of the coding sequence is a hallmark of
mammalian promoters [39,40]. Consequently, promoter predic-
tion programs recognize this region as a second promoter. Inter-
estingly, this prediction is in line with a second GenBank® PHD2
mRNA sequence assembled from ESTs (GenBank® accession no.
AJ310543), which gives a 5′-UTR of approx. 100 bp.
Embedded in this CpG island, we have identified a putative
HBS, by sequence analysis, situated −412 bp relative to the trans-
lational start site. Interestingly, the HBS as well as the surround-
ing sequence is conserved in the murine phd2 gene (Figure 1A),
which suggests functional relevance. Indeed we have shown that
hypoxic induction of murine phd2 is dependent on HIF-1.
Our sequence analysis suggested that two promoters are located
upstream of the PHD2 coding sequence. The upstream promoter
element which is located approx. 3.5 kb 5′ of the transcription
start site is inactive in our experimental setting. Interestingly,
truncation of this promoter region had an activating effect. It seems
possible that a repressor element inhibited transcription initiation
by this promoter region. Our results do not preclude the possibility
that this promoter is active in a different cellular background or at a
different stage of development. The dominant promoter, however,
is situated in a CpG island immediately 5′ of the translation start
site and contains a functional HRE. The different transcripts de-
tected by Northern blotting in previous reports [20,23,33] and
in our experiments are explained by the use of three separate
poly(A)+ signals. The possibilities for the production of distinct
PHD2 transcripts are summarized in Figure 4.
Two further reports add complexity to the situation: alternative
splicing has been described in [41] for exons 3 and 4. We have not
reproduced these data, but as these exons span 207 bp only, alter-
native splicing cannot account for the different transcripts we
have noted. Secondly, the existence of a gene termed scand2 that
has probably evolved by retroposition of the phd2 gene has been
demonstrated [33]. Scand2 is located on chromosome 15q25, and
several transcript variants have been reported. The functions of
this gene as well as its regulation are unclear so far. However,
since large blocks of nucleotide sequence are highly conserved,
it seems mandatory to align the phd2 and scand2 sequences and
to choose hybridization probes and oligonucleotide primers from
unique regions to avoid confounding results.
In essence, we have identified the dominant promoter of the
phd2 gene 0.5 kb 5′ of the translational start site. The promoter
Figure 4 Illustration of the two GenBank® entries potentially leading to distinct PHD2 mRNA species
A transcript containing the extended 5′-UTR and the extended 3′-UTR would encompass 7.5 kb and has not been detected yet. The ‘5′-specific probe’ and ‘3′-specific probe’ designate regions
of the phd2 gene used to detect transcripts containing the extended 5′-UTR and the extended 3′-UTR respectively.
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is located in a CpG island, contains a functional HBS, and thus
confers hypoxic inducibility. By identification of this cis-acting
regulatory element, PHD2 is classified as a direct HIF target gene.
As PHD2 seems essential in the regulation of HIF-1, our findings
may add to the understanding of mammalian oxygen sensing.
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Prolyl 4-hydroxylase domain (PHD) proteins are oxygen-de-
pendent enzymes that hydroxylate hypoxia-inducible transcrip-
tion factor (HIF) -subunits, leading to their subsequent ubiq-
uitination anddegradation. Paradoxically, the expression of two
family members (PHD2 and PHD3) is induced in hypoxic cell
culture despite the reduced availability of the oxygen co-sub-
strate, and it has been suggested that they become functionally
relevant following re-oxygenation to rapidly terminate the HIF
response. Here we show that PHDs are also induced in
hypoxic mice in vivo, albeit in a tissue-specific manner. As
demonstrated under chronically hypoxic conditions in vitro,
PHD2 and PHD3 show a transient maximum but remain up-
regulated over more than 10 days, suggesting a feedback
down-regulation of HIF-1which then levels off at a novel set
point. Indeed, hypoxic induction of PHD2 and PHD3 is par-
alleled by the attenuation of endogenous HIF-1. Using an
engineered oxygen-sensitive reporter gene in a cellular back-
ground lacking endogenous HIF-1 and hence inducible
PHD expression, we could show that increased exogenous
PHD levels can compensate for a wide range of hypoxic con-
ditions. Similar data were obtained in a reconstituted cell-
free system in vitro. In summary, these results suggest that
due to their high O2 Km values, PHDs have optimal oxygen-
sensing properties under all physiologically relevant oxygen
concentrations; increased PHDs play a functional role even
under oxygen-deprived conditions, allowing the HIF system
to adapt to a novel oxygen threshold and to respond to
another hypoxic insult. Furthermore, such an autoregulatory
oxygen-sensing system would explain how a single mecha-
nismworks in a wide variety of differently oxygenated tissues.
Biological systems tightly monitor acute changes in environ-
mental conditions, initiate regulatory responses, and use nega-
tive feedback loops to limit the extent of these responses. To
adapt to chronic changes, many environmental sensors are
capable of adjusting their threshold values, allowing to respond
again to acute deviations of a now different set point.
Cells sense changes in environmental oxygen availability by a
group of enzymes that directly control the cellular response to
lowered oxygen by destabilizing hypoxia-inducible factor
(HIF)2  subunits, the master transcriptional regulators of the
hypoxic response. These oxygen-sensing enzymes have alter-
natively been termed prolyl 4-hydroxylase domain (PHD), HIF
prolyl hydroxylase (HPH), or egg laying defective nine homolog
(EGLN). The following three family members are known up to
date: PHD1/HPH3/EGLN2, PHD2/HPH2/EGLN1, and PHD3/
HPH1/EGLN3 (1–3). PHDs hydroxylate HIF-1 andHIF-2 at
two distinct proline residues within the HIF oxygen-depend-
ent degradation (ODD) domain. Under normoxic conditions,
prolyl 4-hydroxylation allows binding of the vonHippel-Lindau
tumor suppressor protein (pVHL), leading to polyubiquitina-
tion and proteasomal destruction (4). Under hypoxic condi-
tions, prolyl 4-hydroxylation is reduced, and HIF-1 and
HIF-2 become stabilized, heterodimerize with the constitu-
tively expressed HIF-1 subunit aryl hydrocarbon receptor
nuclear translocator (ARNT), and regulate the expression of a
large number of effector genes involved in adaptation to low
oxygen (5). In addition, factor inhibiting HIF hydroxylates a
C-terminal asparagine residue, thereby regulating the tran-
scriptional activity of HIFs (6–8).
Upon re-oxygenation, the PHD oxygen-sensing systemmust
be rapidly reversed. Interestingly, PHD2 and PHD3, but not
PHD1, have been reported to be hypoxically induced at both the
mRNA and protein levels (2). Accordingly, elevated PHD2 and
PHD3 levels have been demonstrated in a broad panel of estab-
lished cancer cell lines (9). Functional hypoxia-response ele-
ments are located in the promoter region of the human PHD2
gene as well as in the first intron of the human PHD3 gene,
suggesting that PHD2 and PHD3 are HIF target genes them-
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cally lacking under hypoxic conditions, the HIF-dependent
hypoxic increase in PHD abundance has been suggested to play
a role in accelerating the termination of the HIF response fol-
lowing re-oxygenation (2, 9, 12, 13). Indeed, biochemical
in vitro studies revealed Km values of purified PHDs for oxygen
close to the oxygen partial pressure (pO2) in air, suggesting that
the kinetics of specific HIF hydroxylation under hypoxic con-
ditions are rather slow (14).However, tissues in situhave to deal
with a great variability of generally very low pO2 values, even
when the inspiratory pO2 is considered to be “normoxic.” We
therefore raised the question whether HIF-dependent regula-
tion of PHD levelsmight lead to the adaptation of the PHD-HIF
oxygen-sensing system to a given tissue pO2, rather than simply
accelerating HIF destruction following re-oxygenation. Such
a self-regulatory loop might define a tissue-specific threshold
for HIF activation as a function of local pO2.
EXPERIMENTAL PROCEDURES
Cell Culture—All cells were maintained in Dulbecco’s
modified Eagle’s medium-high glucose, containing 4.5
mg/ml glucose (Sigma) to maintain cellular energy metabo-
lism during prolonged hypoxic culturing. Culture media
were supplemented with 10% heat-inactivated fetal calf
serum, 50 IU/ml penicillin, and 50 g/ml streptomycin
(Invitrogen). Mouse embryonic fibroblast (MEF)-Hif1a/
and MEF-Hif1a/ and mouse hepatoma Hepa1 and
Hepa1c4 were cultured as described before (15, 16). For long
term hypoxia, MEFs were grown under 2% O2 for up to 256 h
in a gas-controlled glove box to allow for handling of the cells
under constant pO2 (InvivO2 400, Ruskinn Technologies,
Leeds, UK). Cells were grown on 145-mm culture dishes and
split every 48 h. Reagents used for splitting and permanent
culturing were pre-equilibrated to the pO2 in the glove box
before use. For oxygen titration, a single batch of transfected
MEF-Hif1a/ cells was distributed into different hypoxic
incubators (Binder, Tuttlingen, Germany) and simulta-
neously cultured for the indicated time periods.
Protein Extractions and Immunoblot Analyses—Cells were
washed twice and scraped into ice-cold phosphate-buffered
saline. Soluble cellular protein was extracted with a high salt
extraction buffer containing 0.1% Nonidet P-40 essentially as
described before (17). Protein concentrations were deter-
mined by the Bradford method, and 50–80 g of protein
were subjected to immunoblot analysis. Antibodies were
obtained from the following sources: anti-human HIF-1
mouse monoclonal antibody (mAb), BD Transduction Lab-
oratories; anti-human PHDs rabbit polyclonal antibodies,
Novus Biologicals (Littleton, CO); anti-V5 tag mAb, Invitro-
gen; anti--actin mAb, Sigma; horseradish peroxidase-cou-
pled secondary antibodies, Pierce. Anti-human PHD3 mAb
was kindly provided by P. J. Ratcliffe (Oxford, UK). Bound
antibodies were detected with ECL substrate (Pierce), and
chemiluminescence was quantified with a CCD camera-
based light imaging system (FluorChem8900, AlphaInno-
tech, Witec, Littau, Switzerland) using QuantityOne soft-
ware (Bio-Rad).
mRNA Quantification—Exposure of mice to inspiratory
0.1% carbon monoxide or 7.5% oxygen and serum erythro-
poietin quantifications by radioimmunoassay have been
published previously (18–20). Total RNA from tissue and
cells was purified as described before (17). RNA concentra-
tions were determined spectrophotometrically, and RNA
integrity was monitored by denaturing formaldehyde/agar-
ose gel electrophoresis. Total RNA (5 g) was reverse-tran-
scribed using oligo(dT) and Stratascript reverse tran-
scriptase (Stratagene, La Jolla, CA). mRNA levels for mouse
carbonic anhydrase (CA) IX, glucose transporter (GLUT) 1,
erythropoietin, and PHD1, PHD2, and PHD3 were quanti-
fied with 2l of diluted cDNA reaction (corresponding to 1%
of cDNA reaction) by real time RT-PCR. A SybrGreen qPCR
reagent kit (Sigma) was used in combination with an
MX3000P light cycler (Stratagene). Initial template concen-
trations of each sample were calculated by comparison with
serial dilutions of a calibrated standard. To control for equal
input levels, ribosomal protein S12 mRNA was determined,
and data were expressed as ratios relative to S12 levels. Melt-
ing point analyses of amplified PCR products were per-
formed after each run to verify specific amplification. For
primer sequences see Supplemental Material.
Plasmid Constructions—Plasmids encoding full-length
mouse HIF-1, both wild-type and P402A and/or P563A
mutants (note that all amino acid numbering corresponds to
mouse HIF-1 sequences), were a kind gift of L. Poellinger
(Stockholm, Sweden). A PCR product spanning the HIF-1
ODD region (amino acids 359–685) was cloned into the EcoRI
site of pM3-VP16 (Clontech) to obtain one-hybrid constructs
harboring an N-terminal GAL4 DNA-binding domain and a
C-terminal VP16 transactivation domain. Resulting plasmids
were termed G4.mHIF(359–685).VP16_wt, G4.mHIF(359–
685).VP16_P402A, G4.mHIF(359–685).VP16_P563A, and
G4.mHIF(359–685).VP16_PP/AA. For overexpression in
mammalian cells, full-length human PHD2 and PHD3 (kindly
provided by W. Kaelin, Jr., Boston, and I. Flamme, Wuppertal,
Germany, respectively) were subcloned into pENTR4 and
recombined into pcDNA3.1/nV5-DEST using Gateway tech-
nology (Invitrogen). Similarly, vectors for expression of GST-
tagged PHD isoforms in Sf9 insect cells were constructed by
recombining coding sequences for PHD2 and PHD3 into
pDEST20 (Invitrogen). All primary cDNA inserts were
sequenced (Microsynth, Balgach, Switzerland).
Transient Transfections—Cells were co-transfected with the
indicated amounts of DNA using polyethyleneimine (Poly-
sciences, Warrington, PA). Therefore, cells were grown on
100-mm dishes to subconfluency, and 200 l of 150 mM NaCl
containing a DNA/polyethyleneimine mixture (1:5, w/w) was
added. For co-transfections, total DNA was kept constant by
adding empty vector. Following overnight incubation, the cells
were trypsinized and divided onto 12-well plates for luciferase
assays and 100-mm dishes for immunoblotting.
Luciferase Assays—MEF-Hif1a/ cells were transiently co-
transfected with 2 g of the indicated G4.mHIF(359–
685).VP16 fusion constructs and up to 8 g of the respective
V5.PHD isoform, along with 1 g of the GAL4-responsive
reporter plasmid pGRE5xE1b, containing the firefly lucifer-
ase gene under control of E1b promoter and five GAL4
response elements (kind gift of D. Peet, Adelaide, Australia).
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Identical amounts of total DNAwere transfected in each exper-
imental setting. Following transfection, cultureswere grown for
an additional 24 h at the indicated oxygen concentration and
lysed in 100 l of passive lysis buffer (Promega, Madison, WI).
Luciferase reporter gene activity was determined in a micro-
plate luminometer (Berthold, Regensdorf, Switzerland) using
luciferase firefly substrate (Promega). Protein concentration in
the lysates was determined by a Bradford assay, and relative
luciferase activity was calculated from the ratio between rela-
tive light units and micrograms of protein.
RNA Interference—HeLa cells were plated at a density of 2
105 cells per single well of a 6-well plate. The day after, cells
were transfected in fresh media with 80 nM siRNA duplexes
targeting either human PHD2 (5-ggacgaaagccaugguugcu-
uguua-3, sense strand) or PHD3 (5-gcuauccgggaaauggaacag-
guua-3, sense strand) using Lipofectamine 2000 according to
the manufacturer’s protocol (Invitrogen). After 4 h of culturing
at 20% oxygen, cells were subjected to the indicated oxygen
concentrations and grown for an additional period of 24 h prior
to lysis.
Expression and Purification of PHDs—GSTPHD2 and
GSTPHD3 were expressed in baculovirus-infected Sf9 insect
cells according to the manufacturer’s instructions (Invitrogen).
After 80 h of infection, Sf9 cells were lysed in ice-cold 0.1%
Nonidet P-40, 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 100 mM
glycine, and 10 M dithiothreitol. Crude lysate was cleared by
centrifugation at 20,000 g for 20 min, and supernatants were
incubated with equilibrated glutathione-Sepharose beads
(Amersham Biosciences) for 2 h at 4 °C with gentle agitation.
Beadswerewashed three timeswith phosphate-buffered saline,
and bound protein was eluted with 15mM reduced glutathione,
50mMTris-HCl, pH 8.0, 5% glycerol, and 2M FeSO4. Purity of
recombinant proteins was estimated by SDS-PAGE and Coo-
massie Blue staining.
In Vitro Prolyl 4-Hydroxylation Assays—Enzymatic activ-
ity of recombinant PHD2 and PHD3 was determined by an
in vitro hydroxylation assay performed essentially as
described before (17, 21). Briefly, biotinylated mouse HIF-
1-derived peptides (amino acids 555–573, either wild-type
or P563A mutant) were bound to NeutrAvidin-coated
96-well plates (Pierce). Hydroxylase reactions using purified
recombinant GSTPHD2 or GSTPHD3 enzyme were carried
out for 1 h at room temperature. A polycistronic expression
vector for His6- and thioredoxin-tagged pVHL/elongin
B/elongin C (VBC) complex was kindly provided by S. Tan
(Pennsylvania State University, University Park, PA). VBC
was expressed in bacteria, purified by nickel affinity chroma-
tography followed by ion exchange chromatography (Amer-
sham Biosciences), and allowed to bind to the hydroxylated
peptides. Bound VBC complex was detected by rabbit anti-
thioredoxin antibodies and secondary horseradish peroxi-
dase-coupled anti-rabbit antibodies (Sigma) using the
3,3,5,5-tetramethylbenzidine substrate kit (Pierce). The
peroxidase reaction was stopped by adding H2SO4, and
absorbance was determined at 450 nm in a microplate
reader. For oxygen titration experiments, the assay was per-
formed in the hypoxic glove box. All reagents and solutions
were allowed to equilibrate to the indicated oxygen concen-
tration. Inter-assay comparability was guaranteed by cali-
bration of each experiment to an internal standard curve
using hydroxyproline-containing peptides.
RESULTS
mRNA Levels of Inducible PHD Isoforms Show a Transient
Maximum and Remain Up-regulated during Prolonged
Hypoxia in Cell Culture—To study the kinetics of PHD expres-
sion during prolonged hypoxia (2% O2 for up to 256 h), mRNA
levels of all three PHDswere determined inMEF-Hif1a/ and
MEF-Hif1a/ cells. PHD2 and PHD3 but not PHD1 mRNA
levels were efficiently up-regulated under hypoxic conditions,
peaked after 64–112 h, and remained elevated over the entire
time course (Fig. 1A). As positive controls, mRNA levels of
GLUT1 and CAIX, two well established HIF-1 target genes,
were measured in the same time course. Interestingly, hypoxic
GLUT1 up-regulation followed a similar kinetics as PHD2
mRNA expression, whereas CAIX levels were maximally
induced 48 h later, as observed for PHD3 (Fig. 1A). Because
both PHDs were readily induced after 4 h, we investigated the
early onset of induction in a shorter time course. Induction of
PHD2 and PHD3mRNAwas detectable as early as 60–120min
after hypoxic stimulation (Fig. 1B). None of the PHD isoforms
was induced in hypoxic MEF-Hif1a/ cells, suggesting a non-
redundant role of HIF-1 for hypoxic up-regulation of PHD
mRNA in these cell lines. In addition, a lack of PHD2 and PHD3
mRNA induction was also observed in functionally HIF-1/
ARNT-deficientmouse Hepa1c4 but not wild-typeHepa1 hep-
atoma cells after 38 h of hypoxic stimulation (Fig. 1C). Thus,
these genetically altered cellular models confirm HIF-1-
dependent PHD2 and PHD3 gene expression in both acute and
chronic hypoxia, which has been demonstrated previously
mainly in siRNA experiments (12, 13, 22).
Tissue-dependent Hypoxic Induction of PHD2 and PHD3
mRNA in Mice—To date, no systematic investigation on
hypoxic PHD mRNA induction in vivo was available. Thus, we
assessed the grade of hypoxic PHD2 and PHD3 mRNA induc-
tion in acutely and chronically hypoxic mice.
To examine the effects of acute hypoxia, mice were treated
for 4 h with an inspiratory gas mixture containing 0.1% carbon
monoxide (CO), which induced a rapid onset of severe hypoxia
by blocking 50% of the oxygen-binding sites in hemoglobin
(data not shown). Strong hypoxic induction of erythropoietin
mRNA content in kidney as well as erythropoietin and GLUT1
mRNA in liver and brain confirmed the activation of the HIF
system in thesemice (Fig. 2). The various PHDmRNA isoforms
showed a broad disparity of hypoxic activation; PHD1 was not
markedly regulated by hypoxia in most tissues; PHD2 was
widely induced by hypoxia, albeit at rather low levels; and
PHD3 was strongly induced already following 4 h of tissue
hypoxia in the lung (15.6-fold), liver (5.2-fold), and kidney (3.8-
fold), but only moderate induction factors similar to PHD2
were observed in other organs. Of note, striated muscle tissue
(heart and to some extent tongue) showed the highest nor-
moxic expression values for the inducible PHD2 and PHD3
isoforms.
To investigate the kinetics of PHDmRNA induction under
chronically hypoxic conditions, mice were exposed to
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inspiratory hypoxia (7.5% O2) from 24 to 72 h, and mRNA
levels were determined in liver, kidney, and brain. Although
erythropoietin mRNA expression was induced to a similar
extent in kidney and brain already after 24 h of hypoxia,
erythropoietin mRNA in liver did not increase until 72 h of
hypoxic exposure (Fig. 3A). Consistent with previous find-
ings, serum levels of erythropoietin protein in these animals
highly correlated with mRNA levels in kidney (Fig. 3B).
Unexpectedly, the hypoxic inducibility of the known HIF
target genes GLUT1 and CAIX was rather small. Although
strong hypoxic induction of both proteins in tumors and
tumor-derived cell lines is well established, they were not
induced in liver; only one of them (CAIX) was induced after
prolonged hypoxia in kidney, and both of them showed a
transient induction in brain (Fig. 3C). Nevertheless, these
results confirmed the hypoxic status of the animals. Compa-
rable results were obtained with the inducible PHD2 and
PHD3 isoforms; only PHD2 showed a small, transient
increase in the liver; only PHD3 was induced after prolonged
hypoxia in the kidney; and both of them were transiently
induced in the brain. Thus, under physiological inspiratory
hypoxia, regulation of these genes appears to be more subtle
than under in vitro conditions, in tumor hypoxia, or follow-
ing severe tissue hypoxia in CO-treated mice.
Hypoxic Induction of PHD2 and PHD3 Proteins Is Accompa-
nied by Decreased HIF-1 Protein Levels—Hypoxic up-regula-
tion of PHD2 and PHD3 has the potential to affect protein
abundance of HIF-1 during prolonged hypoxia. To further
elaborate this hypothesis, we quantified protein levels of
HIF-1 as well as PHD2 and PHD3 in different cell lines. As
exemplarily shown for HEK293 cells, endogenous HIF-1 pro-
tein levels decreased concomitantly with the hypoxic increase
of endogenous PHD2 andPHD3 levelswhen cellswere cultured
for up to 72 h at 1% O2 (Fig. 4A). Similar results were obtained
from lysates that were prepared under strictly hypoxic condi-
tions, ruling out the possibility that increased levels of induced
PHD enzymes might have influenced the protein levels of
HIF-1 during lysis. HIF-1mRNA levels in HEK293 were not
significantly altered under the same hypoxic conditions,
whereas PHD2 and PHD3 mRNAs were readily induced after
FIGURE 1. HIF-1 target genes remain elevated during prolonged hypoxia.MEF-Hif1a/ and MEF-Hif1a/ were cultured either at 20 or 2% oxygen for
4–256 h (A) or 15–240min (B). mRNA levels for PHD1, PHD2, PHD3, GLUT1, and CAIXwere quantified by real time RT-PCR and normalized to ribosomal protein
S12 mRNA content. C, PHD1, PHD2, and PHD3mRNA levels in Hepa1 Arntwild-type (wt) and Hepa1c4 Arntmutant (mt) cells cultured at 20, 2, or 0.2% oxygen
for 38 h. Data are given as mean S.E. of n 3 independent experiments.
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4 h of hypoxia (Fig. 4B). Interestingly, hypoxic PHD3 mRNA
induction was steadily induced during the entire hypoxic incu-
bation, whereas PHD2 mRNA levels reached maximal induc-
tion already before 4 h of hypoxia and remained constant for up
to 72 h of hypoxia.
A similar pattern of HIF-1 and PHD protein levels was
observed in HeLa and Hep3B cells at oxygen concentrations as
low as 0.2%, supporting the idea of a widespread regulative
mechanism (see supplemental Fig. 1). These observations sug-
gest that even under very limited oxygen supply, HIF-1
hydroxylation by PHDs functionally persists, implicating that
HIF-1 turnovermight be controlled by the PHDsensor system
not only under normoxic conditions but also under severely
hypoxic conditions.
A Second Hypoxic Insult Activates Another HIF-1 Response
in Cells Adapted to Chronic Hypoxia—If the novel HIF-1 pro-
tein base line following adaptation to chronic hypoxia indeed
resulted from an altered steady state of the HIF-PHD oxygen-
sensing circuit, the adapted cells should react to a second,more
severe hypoxic insult by acutely inducing HIF-1 to a similar
extent as at the first hypoxic insult. To test this hypothesis,
HEK293 cells were allowed to adapt to 1% oxygen for 72 h
before theywere exposed to 0.2%oxygen for up to 4 h.Although
HIF-1 levels markedly decreased during chronic hypoxia, a
rapid re-accumulation of HIF-1 protein was already
observed 1 h after exposing the cells to 0.2% oxygen (Fig. 4C).
A similar result was obtained when cells adapted to chronic
hypoxia were treated with the PHD inhibitor dimeth-
yloxalylglycine (DMOG), suggesting that PHDs are respon-
sible for HIF-1 regulation even in hypoxically adapted cells
(Fig. 4D).
PHD2 and PHD3 Silencing Increases Hypoxic HIF-1
Accumulation—As inHEK293 cells, simultaneous treatment of
HeLa cells with hypoxia together with the PHD inhibitor
DMOG led to additional accumulation of HIF-1 at oxygen
concentrations as low as 0.2% (Fig. 5A). To provide further evi-
dence that endogenous PHDs control HIF-1 protein levels
even under hypoxic conditions, we applied siRNA to knock
down PHD2 and PHD3 inHeLa cells. Interestingly, silencing of
either PHD2 or PHD3 equally increased HIF-1 levels, irre-
spective of whether the cells were cultured at 20 or 1% oxygen
(Fig. 5B). Although apparently both isoforms are involved in
regulatingHIF- stability over a broad range of oxygen concen-
trations, combined silencing of PHD2 together with PHD3
most efficiently up-regulated HIF-1 at 20% as well as 1% O2
(Fig. 5B).
PHDs Retain Functional HIF-1 Degradation Activity Even
under Severely Hypoxic Conditions in Cell Culture—Current
knowledge about oxygen substrate requirements of the PHD-
dependent hydroxylation reaction is exclusively based on
data derived from biochemical in vitro studies using purified
enzymes and short peptides containing one single HIF-1
hydroxylation site as substrates. To further examine the
activity of PHD enzymes under lowered oxygen availability
in a cellular context, a luciferase-based mammalian one-hy-
brid approach to quantify HIF-1 stability in a feedback-
uncoupled cellular system was established. A series of mam-
malian expression vectors coding for the mouse HIF-1
ODD domain, including mutant forms of the hydroxylation
sites (P402A and/or P563A), were N-terminally fused to the
yeast GAL4 DNA-binding domain and C-terminally fused to
the herpes simplex virus VP16 transactivation domain (Fig.
6A). The expressed fusion proteins cannot transactivate
endogenous HIF target genes, including PHD2 and PHD3,
but activate a co-transfected GAL4-responsive reporter
gene. The use of HIF-1-deficient MEF-Hif1a/ cells
ensures very low basal levels of endogenous PHDs (Fig. 1A)
and avoids confusion with hypoxic up-regulation of endog-
enous PHD2 and PHD3 by endogenous HIF-1, allowing us to
experimentally define the PHD levels by transfection of
FIGURE 2. Effects of tissue hypoxia on the inducibility of PHD isoforms
in vivo. Tissues were derived from mice kept either under normal air (FiCO
0%) or in a gas mixture containing 0.1% CO (FiCO 0.1%) for 4 h. PHD1, PHD2,
PHD3, erythropoietin, and GLUT1mRNA levels were determined by real time
RT-PCR and normalized to S12 mRNA. Organ-specific hypoxic induction fac-
tors are indicated below the bars. Note the different scales (n.d., not
detectable).
Increased PHDOxygen Sensors Compensate for Low pO2
23486 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 33•AUGUST 18, 2006
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on M
ay 6, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
expression vectors. Because the
HIF-1-ODD confers oxygen-de-
pendent instability to the fusion
protein, luciferase reporter gene
activity directly reflects protein
stability.
First, we tested the relative
importance of the two PHD target
proline residues within the mouse
HIF-1-ODD residues 359–685.
Although reporter gene activation
of the wild-type and single proline
mutant fusion proteins was simi-
larly reduced by PHD2 overexpres-
sion, mutation of both prolines was
necessary to render the HIF-1-
ODD insensitive to PHD2 overex-
pression (Fig. 6B). Although similar
effects of PHD overexpression on
ODD stability have been reported
previously only for normoxic condi-
tions (23), our data show functional
relevance of both hydroxylation sites
also for hypoxic (2%O2) regulation of
HIF-1 protein levels (Fig. 6B).
In the next step, both oxygen con-
centration and PHD protein abun-
dance were titered simultaneously
in co-transfection experiments.
Interestingly, co-expression of low
amounts of PHD2, which were not
yet detectable by immunoblotting,
already reduced HIF-1-ODD sta-
bility to a minimum, which was not
further lowered by increased
amounts of PHD2 (Fig. 6C). Reduc-
ing the oxygen concentration to 4%
or below revealed a successive
decrease of hydroxylase activity at a
given amount of PHD2 enzyme.
However, increasing the abundance
of PHD2 by stepwise duplication of
the amount of transfected PHD2
expression vector again demon-
strated that induced PHD levels can
compensate for reducedoxygenavail-
ability. Indeed, increased PHD2 com-
pensated for oxygen concentrations
as low as 0.2% (Fig. 6C).
Similar results were obtained by
PHD3 overexpression, which also
resulted in decreased HIF-1-ODD
stability under normoxic and mod-
erately hypoxic conditions (Fig. 6D).
However, forced expression of
PHD3 failed to further decrease
HIF-1-ODD stability at 0.2% oxy-
gen, suggesting a principal differ-
FIGURE 3. Effects of inspiratory hypoxia onHIF target gene expression in vivo.Micewere kept at an FiO2 of
20% O2 (0 h of hypoxia) or 7.5% O2 for up to 72 h. Erythropoietin mRNA levels in liver, brain, and kidney were
quantified by real time RT-PCR (A), and corresponding serum levels of erythropoietin weremeasured by radio-
immunoassay (B). C, GLUT1, CAIX, PHD2, and PHD3mRNA levels were measured in all three tissues. All mRNA
data were normalized to S12 mRNA levels and are expressed as hypoxic induction factors. Bars represent the
mean S.E. of n 3 mice per group.
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ence in oxygen-dependent hydroxylase activities between
PHD2 and PHD3 under various degrees of hypoxia in vivo
(Fig. 6D).
Purified PHDs Retain Functional
Hydroxylation Activity Even under
Severe Hypoxic Conditions in a Cell-
free System in Vitro—The differ-
ences in hydroxylase activity of
PHD2 and PHD3 under severe
hypoxia described above prompted
us to investigate the activity of
PHDs using a cell-free in vitro
approach. Therefore, GST-tagged
PHD2andPHD3were purified from
baculovirus-infected Sf9 insect cells
(Fig. 7A). These enzymes were used
to hydroxylate a mouse HIF-1-
ODD-derived peptide coupled to
96-well plates, and binding of a puri-
fied VBC complex to the hydroxy-
lated peptide was measured by
enzyme-linked immunosorbent
assay. Each PHD preparation was
diluted to obtain equal VBC binding
after 1 h of hydroxylation (arbi-
trarily defined as “1-fold input”).
These enzyme concentrations were
subsequently increased to mimic
the hypoxic induction of PHDs
in vivo. Under normoxic conditions,
both PHDs showed a similar
increase in activity with increasing
protein amounts (Fig. 7A). Peptide
hydroxylation was within the linear
range of the assay over the time
frame of experiments, even at high-
est enzyme concentrations (data not
shown).
When the assay was performed at
an oxygen concentration of 2%,
PHD2 hydroxylation activity was
only about half of the normoxic
activity after 1 h of reaction
(hydroxyproline contents of 10.1 
0.2% at 20%O2 and 5.7 0.5% at 2%
O2; n  3, mean  S.D.; 8-fold
enzyme input). However, HIF-1-
ODD peptide hydroxylation by
PHD3 was only slightly decreased
under these conditions (10.3 0.2%
at 20% O2 and 8.2  1.1% at 2%
O2; n  3, mean  S.D.; 8-fold
enzyme input). Further reduction
in oxygen availability decreased
proline hydroxylation, but signifi-
cant hydroxylation could still be
observed at oxygen concentrations
as low as 0.2%. Indeed, an 8-fold
protein input of PHD2 or PHD3 resulted in similar peptide
hydroxylation at 0.2%O2 as a 4-fold input at 0.5%O2 or a 2-fold
input at 1% O2, suggesting that increased PHDs can compen-
FIGURE 4.DecreasedHIF-1protein levels parallel increasedPHD2andPHD3under chronically hypoxic
conditions. A,HEK293 cells were cultured at 20 or 1% oxygen for up to 72 h. HIF-1, PHD2, PHD3, and -actin
(loading control) protein levelswere estimatedby immunoblottingof total cell lysates. A representative exper-
iment is shown alongwith densitometric quantification of bands for n 3 (PHDs) or n 4 (HIF-1) independ-
ent experiments. For inter-assay normalization, time points expressing highest protein levels were arbi-
trarily defined as 1 (filled circles; mean S.E.). B,HIF-1, PHD2, and PHD3mRNA levels in HEK293 cells were
quantified by real time RT-PCR and normalized to ribosomal protein L28 mRNA. Bars represent mean 
S.E. of triplicate experiments. C, HEK293 cells were exposed to 1% oxygen for 72 h and subjected to 0.2%
oxygen for additional 1–4 h without reoxygenation. Lowering the oxygen concentration from 1 to 0.2%
took30min. Immunoblottingwas performed as in A.D,HEK293 cells were grown as in C and treatedwith
a PHD inhibitor (“”, 1 mM DMOG) or solvent alone (“”, 0.1%Me2SO) for 1–4 h at 1%O2. Immunoblotting
was performed as described in A.
FIGURE5.EndogenousPHD2andPHD3enzymes controlHIF-1accumulationundernormoxic aswell as
under hypoxic conditions. A, HeLa cultures were subjected to 20, 1, or 0.2% oxygen for 4 h and simulta-
neously treated with a PHD inhibitor (, 1 mM DMOG). PHD2, PHD3, HIF-1, and -actin protein levels were
determined by immunoblotting of total cell lysates. B, HeLa cells were transiently transfected with siRNAs
directed against either PHD2, PHD3, or a combination of both and were cultured at the indicated oxygen
concentrations for 24 h. Transfection of cells with a similarly constructed but unspecific siRNA oligonucleotide
served as negative control (“C”). Immunoblotting was performed as described above.
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sate for decreased oxygen also in vitro (Fig. 7A).Moreover, both
enzymes showed a strikingly linear increase of activity for the
range of 0.2 to 2% oxygen, thus fulfilling one of themost impor-
tant criterions for a cellular oxygen sensor at physiologically
relevant tissue O2 concentrations (Fig. 7B).
DISCUSSION
The existence of a functional feedback loop limiting the
hypoxic response has been suspected already when HIF was
cloned, because nuclear HIF-1 declined despite ongoing
hypoxia (24). Similar observationswere then reported by amul-
titude of other groups. However, the underlying mechanism
remained unknown. We previously reported that forced
expression of HIF-1 followed a similar feedback kinetics, but
in this case under normally oxygenated conditions (25). This
observation suggested that HIF itself, rather than the hypoxic
stimulus, is required for the feedback regulation. One such
mechanism might be HIF-dependent induction of pVHL by
“late hypoxia” (26). However, other studies could not find any
FIGURE 6. PHD2 and PHD3 retain hydroxylase activity at low oxygen
concentrations. A, oxygen-sensitive one-hybrid fusion constructs. Muta-
tions of Pro-402 and Pro-563 are underlined. B, MEF-Hif1a/ cells were
co-transfected with 2 g of one-hybrid construct, 1 g of a GAL4-respon-
sive reporter gene, and 1 g of V5.PHD2 or empty expression vector.
Luciferase activity wasmeasured 24 h after incubation at 20 or 2% oxygen,
and relative light counts were normalized to total protein content in the
lysates. Likewise, the indicated amounts of V5.PHD2 (C) and V5.PHD3 (D)
were co-transfected with 2 g of the wild-type (wt) one-hybrid construct
and 1 g of the reporter gene. Aliquots of transfected cells were then
cultured simultaneously at various oxygen concentrations, and luciferase
activities were determined after 24 h as described above. In addition,
lysates were immunoblotted to verify expression of exogenous V5.PHD
isoforms (bottom panels). Representative experiments performed in trip-
licate experiments are shown as means  S.E.
FIGURE 7. Recombinant GSTPHD2 and GSTPHD3 proteins are active
underhypoxic conditions invitro.A,GST.PHD2andGST.PHD3werepurified
from baculovirus-infected Sf9 insect cells, and their purity was checked by
SDS-PAGEandCoomassie Blue staining (CBS) or by immunoblotting (IB) using
polyclonal anti-PHD2 or anti-PHD3 antibodies. In vitro hydroxylation reac-
tions were performed at various oxygen concentrations with increasing
amounts of PHD2 and PHD3 enzymes, and hydroxyproline content was esti-
mated from a calibration curve. B, oxygen dependence of hydroxylation is
shown for 8-fold enzyme input. Enzyme activity is given as percentage of
hydroxyproline after 1 h of reaction. All values are in the linear range of the
assay and are shown as mean values S.E. of triplicate experiments.
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induction of pVHL under hypoxic conditions (27, 28), and we
did not observe any oxygen- orHIF-1-dependent difference in
pVHL mRNA levels during the 256-h time course described in
this study (data not shown).
The identification of the PHD oxygen sensors shed new light
on the process of HIF feedback control, as it became clear that
PHD2 and PHD3 are hypoxia-inducible HIF target genes (2,
9–13, 29). It has been postulated that this PHD up-regulation
confers accelerated degradation of HIF upon re-oxygenation
(9, 12, 22). Indeed, re-oxygenation from 1 to 20.9% (air) oxygen
after 18 h decreased the half-life of HIF-1 when compared
with similarly treated cells that were exposed to hypoxia for
only 1 h (12).
However, physiological tissue pO2 corresponds to 2–5%
oxygen concentrations in air rather than the widely used 20.9%
normoxic oxygen concentration. Even though the pericellular
pO2 is lower at the bottom of unstirred tissue culture dishes
(30), standard cell culture conditions are to be considered
“hyperoxic,” which reflects an unphysiological condition to
which PHDs are not normally exposed. Rather, PHDs in vivo
are constantly functioning under pO2 levels far below their
in vitro Km values (14). These considerations suggested a PHD-
HIF feedback loop that might be active even under chronically
low tissue oxygenation.
In line with this hypothesis, we observed undulatingHIF-1-
dependentmRNA levels of CAIX,GLUT1, PHD2, and PHD3 in
MEF cells, and we detected tissue-specific variations in hypoxi-
cally induced PHD2 and PHD3mRNA levels inmice in vivo. So
far, PHD expression levels were only known from established
tumor cell lines or normoxic tissues (9, 10, 22, 31–33). We
found an impressive up-regulation of PHD3 mRNA levels in
hypoxic lung tissue, confirming previous reports for lung can-
cer-derivedA549 cells (9, 28). Similarly, the observed induction
factors in liver were roughly the same as determined in Hepa1
hepatoma cells used in this study.
We then concentrated on threemajor organ systems that are
particularly sensitive to hypoxia and hence involved in the
pathophysiology of shock. Interestingly, although the examined
HIF target genes were all induced in the brain, different kinetics
for GLUT1, CAIX, PHD2, and PHD3 were observed in kidney
and liver. Expression levels of CAIX were highly increased in
the kidney after 72 h of hypoxia, whereas a reverse effect was
observed in liver. Because the kidney, besides the lung, is the
major organ involved in systemic pH regulation, these results
suggest a physiological role for CAIX in pH maintenance dur-
ing hypoxia, as has been proposed for solid tumors (34).
Regarding PHDmRNA induction, temporal up-regulation of at
least one isoform was observed in each of the three tissues in
hypoxic animals, confirming that PHD up-regulation indeed
occurs in a hypoxic organism, although the extent of induction
is tissue-specific. Not surprisingly, decreasing the oxygen trans-
port capacity in mice by 0.1% CO inspiration was much more
efficient in up-regulation of HIF target genes than inspiratory
hypoxia itself, suggesting that adaptational mechanisms, such
as increased heart rate, depth of breath, and reduced oxygen
consumption compensated for decreased inspiratory O2 con-
centration when oxygen transport is intact. We have shown
previously that temporal and spatial accumulation of HIF-1
in vivo greatly differs, even in neighboring cells, suggesting that
factors other than oxygen availability affect the PHD-HIF sys-
tem (35). In fact, we recently found that the FK506-binding
protein FKBP38 regulates specifically the abundance of PHD2.3
Whatever regulates cellular PHD levels, functional PHD
induction requires that these enzymes must be active under a
broad range of physiologically relevant conditions. In order to
experimentally support this hypothesis, we used a HIF-1-
ODD reporter construct in aHIF-1negative cell line to breach
the suggested gene activation-protein degradation loop. The
HIF-1-ODD confers normoxic degradation to the resulting
hybrid fusion protein (36), and similar constructs have been
used lately as bioluminescent reporter systems monitoring the
state of tissue oxygenation in vivo (37). Our experiments
revealed that PHD-dependent fusion-protein destabilization
was effective at oxygen concentrations as low as 0.2% O2 and
that increasing the amount of enzyme partially compensated
for reduced oxygen availability. These data are consistentwith a
recent work (38) employing hydroxylation-specific antibodies
that showed persistent HIF-1 hydroxylation at equally low
oxygen concentrations.
Although we observed a comparable oxygen dependence
between PHD2 and PHD3 purified from Sf9 insect cells in vitro,
the ability of PHD3 to compensate for low oxygen concentra-
tions in the cellular model was consistently lower than that of
PHD2 (compare Fig. 6, C andD). In line with the former obser-
vation, in vitro transcribed and translated PHD2 and PHD3
enzymes have been shown to be equally active in another study
(39). Thus, isoform-specific regulation of distinct PHDs in vivo
is likely to depend on critical co-factors that might be depleted
in purified enzyme preparations or become limitedwhen PHDs
are overexpressed. Supporting this notion, PHD3 has recently
been described to serve as a substrate of the eukaryotic chap-
eronin complex TRiC that might be required for appropriate
folding and full enzymatic activity (40).
Another recent work demonstrated increased binding of
PHD3 to HIF-1 in the presence of OS-9 (41). As suggested by
these authors, PHDs form functional multiprotein complexes
that could affect binding affinity and target sequence selectivity
in a cellular context. However, binding of OS-9 to human
HIF-1 necessarily requires amino acids 692–785 that were
neither present in the peptide used for the hydroxylation assays
nor in the one-hybrid construct. Thus, PHD3 activity rather
than binding might be attenuated in our cellular model system.
Of note, protein degradation of PHD3 (and PHD1) has been
shown to be enhancedunder hypoxia by amechanism involving
the ubiquitin ligase Siah2, adding yet another layer of regulation
on the HIF-PHD system (42).
Also, binding of PHD2 to HIF-1 has been suggested to
repress the N-transactivation domain activity (43). Interest-
ingly, we observed residual binding of recombinant PHD2 to
immobilized HIF-1 ODD peptides in vitro, suggesting a
repressive function of PHD2 particularly on truncated HIF-1
(data not shown). Although these effects were rather small
compared with the HIF-1-destabilizing function of enzymatic
3 S. Barth, R. Wirthner, R. H. Wenger, and G. Camenisch, manuscript in
preparation.
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PHD activity, they still could have partially influenced the tran-
scriptional activity of the fusion constructs used in our study.
In conclusion, the present work demonstrates that an essen-
tial pre-requirement for a PHD abundance-dependent modu-
lation of the oxygen-sensing system is fulfilled; PHDs are oper-
ative under a wide variety of even severely hypoxic oxygen
concentrations. These findings led to the intriguing suggestion
of a flexible oxygen threshold of the PHD-HIF system that
steadily adapts to altered tissue oxygenation.
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gene species Genbank forward primer reverse primer
Accession No.
CAIX mouse AJ245857 5'- gctgtcccatttggaagaaa -3' 5'- ggaaggaagcctcaatcgtt -3'
GLUT1 mouse M23384 5'- tctctgtcggcctctttgtt -3' 5'- gcagaagggcaacaggatac -3'
EPO mouse NM_007942 5'- atctgcgacagtcgagttct -3' 5'- gtatccactgtgagtgttcg -3'
PHD1 mouse NM_053208 5'- ttgcctgggtagaaggtcac -3' 5'- gctcgatgttggctaccact -3'
PHD2 mouse NM_053207 5'- gcaacggaacaggctatgtc -3' 5'- ctcgctcatctgcatcaaaa -3'
PHD3 mouse NM_028133 5'- caacttcctcctgtccctca -3' 5'- ggctggacttcatgtggatt -3'
S12 mouse NM_011295 5'- gaagctgccaaagccttaga -3' 5'- aactgcaaccaaccaccttc -3'
PHD2 human NM_022051 5'- gaaagccatggttgcttgtt -3' 5'- ttgccttctggaaaaattcg -3'
PHD3 human NM_022073 5'- atcgacaggctggtcctcta -3' 5'- cttggcatcccaattcttgt -3'
HIF-1α human NM_001530 5'- tccgatggaagcactagaca -3' 5'- tggtgacaactgatcgaagg -3'
L28 human NM_000991 5'- gcaattccttccgctacaac -3' 5'- tgttcttgcggatcatgtgt -3'
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Supplemental Figure 1
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SUPPLEMENTAL FIGURE 1. Reciprocal regulation of HIF-1α and PHD protein levels during 
prolonged hypoxic culturing. Hep3B- and HeLa cells were cultured at 20% or 0.2% oxygen for up 
to 72 hours. HIF-1α, PHD2, PHD3 and β-actin (loading control) protein levels were determined by 
immunoblotting of total cell lysates (75 µg total protein).  
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Regulated Function of the Prolyl-4-Hydroxylase Domain
(PHD) Oxygen Sensor Proteins
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ABSTRACT
Cellular oxygen is sensed by prolyl-4-hydroxylase domain (PHD) proteins that hydroxylate hypoxia-inducible
factor (HIF)  subunits. Under normoxic conditions, hydroxylated HIF is bound by the von Hippel–Lindau
(pVHL) tumor suppressor, leading to ubiquitinylation and proteasomal degradation. Under hypoxic condi-
tions, hydroxylation becomes reduced, leading to HIF stabilization. The authors recently showed that changes
in PHD abundance and activity can regulate HIF stability under normoxic as well as under hypoxic condi-
tions. Thus, the PHD oxygen sensors themselves represent effectors of cellular signalling pathways as well as
potential drug targets. Here, a cell-free in vitro microtiter plate-based peptide hydroxylation assay was used
to investigate the influence of ferrous iron, Krebs cycle intermediates, transition metals, and vitamin C and
other antioxidants on the activity of purified PHD1 to 3. PHD activity depends not only on oxygen availabil-
ity but is also regulated by iron, vitamin C, and Krebs cycle intermediates, suggesting a physiological rele-
vance of their cellular concentrations. Copper but not iron, cobalt, or nickel salts catalyzed vitamin C oxida-
tion. While vitamin C is essential for PHD activity in vitro, N-acetyl-L-cysteine had no effect, and gallic acid
or n-propyl gallate efficiently inhibited the activity of all three PHDs, demonstrating different functions of
these antioxidants. Antioxid. Redox Signal. 9, 1329–1338.
1329
INTRODUCTION
OXYGEN AVAILABILITY affects many physiological andpathophysiological processes, including embryonic de-
velopment, adaptation to high altitudes, wound healing, in-
flammation, cancer, and ischemic diseases such as infarction
and stroke. Central to the understanding of these processes is
the elucidation of the molecular mechanisms by which cells re-
act and adapt to insufficient oxygen supply (hypoxia). Oxygen
availability is measured by a family of oxygen-dependent pro-
tein hydroxylases that regulate the abundance and activity of
hypoxia-inducible transcription factor (HIF)  subunits (47).
HIFs in turn control the expression levels of effector genes in-
volved in either anticipatory metabolic changes, adaptive sur-
vival, or programmed death of the affected tissue (58). HIFs
are heterodimeric transcription factors consisting of one out of
three different oxygen-sensitive HIF subunits (HIF-1, HIF-
2, or HIF-3) and a common constitutive HIF subunit. While
HIF-1 and HIF-2  heterodimers function as transcriptional
activators of oxygen-regulated target genes, the role of HIF-3
is less clear and a short splice variant of HIF-3, termed in-
hibitory PAS protein (IPAS), functions as a transcriptional re-
pressor (57).
Dependent upon the cellular oxygen partial pressure (pO2),
a family of prolyl-4-hydroxylase domain (PHD) enzymes co-
valently modify two proline residues within the oxygen-de-
pendent degradation (ODD) domain of HIF subunits. The
PHD family is comprised of three members called PHD1,
Institute of Physiology and Zürich Center for Integrative Human Physiology (ZIHP), University of Zürich, Zürich, Switzerland.
PHD2, PHD3, or HIF prolyl hydroxylase (HPH) HPH3, HPH2,
HPH1, respectively (7, 14). A fourth member, called PH4, reg-
ulates HIF under overexpression conditions only (40). Upon
hydroxylation under normoxic conditions, HIF is bound by
the von Hippel–Lindau (VHL) tumor suppressor protein and
targeted for proteasomal destruction (35). Thus, the high turn-
over rate of HIF subunits allows for an instantaneous stabi-
lization under hypoxic conditions (21). According to the cur-
rent model, also the asparagine hydroxylase function of the
factor inhibiting HIF (FIH) becomes impaired when oxygen
availability is further decreased, resulting in a decrease in C-
terminal HIF asparagine hydroxylation (44). This allows for
the progressively increased recruitment of p300/CPB tran-
scriptional co-activators, leading to a successively higher tran-
scriptional function of HIF (28, 31).
While all three PHDs can hydroxylate HIF with similar ef-
ficiency, PHD2 has been suggested to play the main role for
normoxic HIF turnover (6). Consistent with these in vitro find-
ings, PHD2 but not PHD1 or PHD3 knock-out mice die during
embryonic development (51). The three PHDs are expressed in
most organs, but there are strikingly high levels of PHD3
mRNA in the heart and of PHD1 mRNA in the testis (50). In
addition to HIF, there is some evidence that the iron regula-
tory protein IRP2, the RNApol II large subunit Rpb1, the heme
synthesis enzyme ALAS2, and IB kinase- are regulated by
PHDs (1, 10, 27, 54, 55). Of note, these experiments were
mainly based on pharmacological inhibition of PHDs and no
direct evidence for protein hydroxylation has been provided yet.
Interestingly, ankyrin repeats within the NF-B family (p105)
and IB were shown to be efficiently hydroxylated by FIH
(9). The function of this FIH-dependent hydroxylation, how-
ever, is unclear up to date.
The regulation of PHD expression and activity has become
of considerable interest in the recent past. Endogenous tricar-
boxylic acid cycle intermediates and reactive oxygen species
(ROS) have been reported to inhibit PHD function and hence
link mitochondrial function with PHD-dependent oxygen sens-
ing (12, 15, 43, 48). Small molecule inhibitors that can be added
exogenously are currently being developed for clinical tissue
protection in diseases associated with oxygen deprivation. How-
ever, little is known on the differential regulation of the three
PHD family members. We therefore set out to investigate the
control of each PHD family member individually by small mol-
ecules as well as by newly identified protein interactors and by
HIF-dependent feedback regulation.
MATERIALS AND METHODS
Expression and purification of PHDs
GST-PHD1, GST-PHD2, and GST-PHD3 were expressed in
baculovirus-infected Sf9 insect cells and purified as described
before (50). Briefly, after 80–110 h of infection, Sf9 cells were
lysed in ice-cold 0.1% NP-40, 10 mM Tris-HCl pH 7.5, 100
mM NaCl, 100 mM glycine, and 10 M DTT. Cleared lysates
were incubated with equilibrated glutathione-sepharose beads
(Amersham, Dübendorf, Switzerland) for 2 h at 4°C with gen-
tle agitation. After washing of the beads three times with PBS,
bound protein was eluted with 15 mM reduced glutathione, 50
mM Tris-HCl pH 8.0, and 2 M FeSO4. Purity of recombinant
fusion-proteins was routinely estimated by SDS-PAGE and
coomassie blue staining.
In vitro prolyl-4-hydroxylation assays
Enzymatic activity of recombinant PHDs was determined as
described before (32, 41). Biotinylated peptides (100 ng/well)
derived from human HIF-1 aa 556 to 574 (either wild-type or
P564A mutant) were bound to NeutrAvidin-coated 96-well
plates (Pierce, Perbio, Lausanne, Switzerland). Purified recom-
binant PHD enzymes were used to hydroxylate the peptides in
the presence of 0.5 mM 2-oxoglutarate, 2 mM ascorbate, 10 M
FeSO4 in 20 mM Tris-HCl pH 7.5, 5 mM KCl, 1.5 mM MgCl2
for 1 h at room temperature. A polycistronic expression vector
for His6- and thioredoxin-tagged pVHL/elongin B/elongin C
(VBC) complex was kindly provided by S. Tan (Pennsylvania,
PA). VBC was expressed in bacteria, purified by nickel affin-
ity chromatography, followed by ion exchange chromatography
and buffer exchange gelfiltration. VBC complex was allowed
to bind to the hydroxylated peptides and bound VBC complex
was detected by rabbit anti-thioredoxin antibodies, followed by
secondary horseradish peroxidase-coupled anti-rabbit antibod-
ies (Sigma, Buchs, Switzerland), using the TMB (3,3,5,5-
tetramethylbenzidine) substrate kit (Pierce). The peroxidase re-
action was stopped by adding H2SO4 to 1 M and absorbance
was determined at 450 nm in a microplate reader.
Ascorbate oxidation assays
Ascorbate oxidation to dehydroascorbate was measured spec-
trophotometrically as described (49). Therefore, the decrease in
absorbance at 265 nm was measured in a 100 M ascorbate so-
lution in 20 mM Tris-HCl pH 7.5, 5 mM KCl, 1.5 mM MgCl2
using open cuvettes with free access to air.
Hypoxia reporter cells
The Chinese hamster ovary (CHO) cell line stably transfected
with a hypoxia-responsive firefly luciferase reporter gene
(termed HRCHO5) has been described before (56). Cell lysis
and determination of luciferase activity was performed accord-
ing to the manufacturer’s instructions (Promega, Wallisellen,
Switzerland). Relative light units were measured in a 96-well
luminometer (Berthold, Regensdorf, Switzerland) and normal-
ized to the protein concentration determined by the Bradford
assay (Biorad, Reinach, Switzerland).
RESULTS
Ferrous iron availability is essential for the
function of all three PHDs
GST-tagged PHD1, PHD2, and PHD3 were purified from
Sf9 insect cells to 80–90% purity and their activities were an-
alyzed by a VBC binding assay. All three PHDs induced VBC
binding to the wild-type P564 but not to the mutant P564A-
containing peptide derived from the HIF-1 ODD (Fig. 1A).
The PHD preparations were calibrated with hydroxyproline
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(Hyp)564 peptide-containing hydroxylation assays and subse-
quently diluted to obtain solutions with similar specific activi-
ties which were then used for all following experiments.
Although 2 M FeSO4 was initially present in the elution
buffer, the PHDs did not display full activity without additional
ferrous iron in the reaction buffer (Fig. 1B), suggesting that
both active center and added iron was at least partially oxidized.
An iron titration experiment revealed that the addition of ~10
M FeSO4 was required for full induction of the hydroxylation
activity of all three PHDs (Fig. 1C). This concentration was
hence kept in the following experiments. The addition of fer-
ric iron did not stimulate the activity of the PHDs (data not
shown).
The sensitivity of the PHDs to the availability of “free” iron
explains the long-known feature of iron chelators to induce the
HIF subunits. Indeed, the hexadentate hydroxamic acid iron
chelator desferrioxamine inhibited the in vitro hydroxylation
activity of all three PHDs (Fig. 1D). Of note, PHD2 was some-
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FIG. 1. Regulation of PHD function by iron. PHD1, PHD2, and PHD3 (from left to right) were purified as GST-tagged fu-
sion-proteins from Sf9 cells and their hydroxylation activity was estimated in microtiter plate-based VBC binding assays. (A)
VBC binding is dependent on the presence of both functional PHD enzyme and Pro564. Mutant P564A peptides cannot be hy-
droxylated. (B) Ferrous iron supplementation is essential for full PHD function. (C) Titration of ferrous iron reveals that ~10 M
FeSO4 is required for full PHD function. (D) Inhibition of PHD function by iron chelation. Mean values  SEM of representa-
tive experiments performed in triplicate are shown.
what less sensitive to desferrioxamine than PHD1 or PHD3,
which were efficiently inhibited by 10 M desferrioxamine,
corresponding to the concentration of iron in the reaction solu-
tion.
Requirement for 2-oxoglutarate and 
inhibition by succinate
2-Oxoglutarate is used as a co-substrate of all three PHDs
which is oxidatively decarboxylated during target protein hy-
droxylation. Titration experiments with 2-oxoglutarate revealed
that all three PHDs required a similar 2-oxoglutarate concen-
tration of ~10–100 M for full activity (Fig. 2A). These data
confirm previous estimates of Km values of 55–60 M for all
three PHDs (17), and a PHD2 binding constant for 2-oxoglu-
tarate of 2 M (36). Therefore, a concentration of 500 M
2-oxoglutarate was kept in all further experiments. Higher con-
centrations of 2-oxoglutarate inhibited the in vitro PHD activ-
ity in some experiments. Whether this effect is of physiologi-
cal relevance is currently unknown.
It has been reported previously that succinate can inhibit PHD
activity (12, 30, 48). We hence tested the effects of increasing
succinate concentration on each PHD enzyme. In the presence
of 500 M 2-oxoglutarate, addition of succinate only moder-
ately inhibited the hydroxylation activity of purified PHDs and
this effect was even reversed at higher concentrations (Fig. 2B).
However, in the presence of 50 M 2-oxoglutarate, succinate
efficiently inhibited PHD activity with IC50 values of ~600 M
(Fig. 2C).
Vitamin C oxidation impairs PHD function
Vitamin C is essential for the function of collagen hydroxy-
lases as well as for HIF hydroxylases because it protects the
enzyme’s amino acid residues and/or active center iron from
oxidation in reactions uncoupled from target hydroxylation
(38). Purified PHDs do not show any activity in the absence of
ascorbate and the addition of at least 0.1 mM ascorbate was re-
quired to fully induce hydroxylation activity of all three PHDs
(Fig. 3A). The addition of oxidized ascorbate (dehydroascor-
bate) did not induce PHD activity (data not shown). These data
confirm previously reported similar ascorbate Km values
(140–180 M) for all three PHDs (17). Therefore, an excess of
freshly prepared ascorbate (2 mM) was added to all subsequent
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FIG. 2. Regulation of PHD function by Krebs cycle intermediates. PHD1, PHD2, and PHD3 (from left to right) hydrox-
ylation activity was estimated in microtiter plate-based VBC binding assays. Titration curves of the cosubstrate 2-oxoglutarate
(A) or the co-product succinate in the presence of 500 M (B), or 50 M (C) 2-oxoglutarate are shown as mean values  SEM
of representative experiments performed in triplicate.
experiments. Antioxidative ascorbate function is specifically re-
quired by the PHDs and cannot be replaced by the antioxidant
N-acetyl-L-cysteine (Fig. 3B).
The absolute requirement for ascorbate might also explain
the function of previously reported agents inhibiting PHD ac-
tivity. Ascorbate oxidation by air can be measured by the drop
in absorbance at 265 nm. However, as shown in Fig. 3C, ascor-
bate oxidation is negligible during the reaction period of 1 h.
Even in the presence of equimolar ferrous iron, the ascorbate
levels dropped only by 20% after 1 h (Fig. 3C, left graph). The
transition metals cobalt and nickel are well-known inducers of
HIF protein stability due to PHD inhibition. Of note, even a
twofold molar excess of CoCl2 or NiSO4 did not catalyze more
ascorbate oxidation than FeSO4 (Fig. 3C, middle graph). In con-
trast, copper efficiently catalyzed ascorbate oxidation: 5 M
CuCl2 destroyed 90% of 100 M ascorbate within 10 min
(Fig. 3C, right graph).
The antioxidants gallic acid and n-propyl gallate
efficiently inhibit the activity of all three PHDs
A number of natural nutrient compounds has been suggested
to induce HIF-1; among them flavonoid and nonflavonoid
polyphenols. Catechins are nonflavonoid polyphenols found in
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FIG. 3. Regulation of PHD function by vitamin C. PHD1, PHD2, and PHD3 (from left to right) hydroxylation activity was
estimated in microtiter plate-based VBC binding assays. (A) Titration of vitamin C reveals that 0.1 mM ascorbate is minimally
required for PHD function. (B) The antioxidant N-acetyl-L-cysteine (250 M) cannot replace ascorbate (2 mM) for PHD func-
tion. (C) Ascorbate is slowly oxidized by air (dehydroascorbate does not absorb light at 265 nm). Ferrous iron slightly catalyzes
this reaction (left graph), whereas the effects of the known PHD inhibitors cobalt and nickel are negligible (middle graph). How-
ever, cupric copper strongly catalyzed ascrobate oxidation (right graph). Mean values  SEM of representative experiments per-
formed in triplicate are shown.
green tea leaves which have been reported to induce HIF-1
(60). Only catechins containing a 3-gallate moiety activate HIF-
1 and have been shown to inhibit PHD2 activity (52, 53). Thus,
we tested the sensitivity of PHD-dependent peptide hydroxyla-
tion on gallic acid or n-propyl gallate. Remarkably, all three
PHDs were efficiently inhibited by 33–100 M gallic acid (Fig.
4A) or by 3.3–10 M n-propyl gallate (Fig. 4B). As shown in
Fig. 4C, n-propyl gallate also induced HIF-dependent lucifer-
ase reporter gene activity in cultured CHO cells. In contrast to
the in vitro results, gallic acid treatment of cells only margin-
ally affected luciferase expression (data not shown).
DISCUSSION
Oxygen sensing by protein hydroxylation 
is a regulated process
Sensing cellular pO2 is probably not the only function of the
PHDs. Otherwise, an excess of a single sensory protein simply
regulated by oxygen availability would be all that was required
for this task. However, there is ample evidence that the PHD
oxygen sensors fulfill additional functions. First, different tis-
sues are differently vascularized, unequally perfused, and show
spatially and temporally variable oxygen consumption rates.
Thus, the mean pO2 varies from tissue to tissue, if not from cell
to cell. Nevertheless, every cell is capable of sensing a reduc-
tion in oxygenation and adequately responds to such a reduc-
tion by inducing HIF-dependent gene expression. Therefore,
also hypoxia thresholds vary both spatially and temporally, and
the PHD oxygen sensors evolved to meet these requirements
by showing a variable tissue-specific expression pattern. Sec-
ond, every successful adaptation to hypoxia eventually results
in reoxygenation of the affected tissue. Because following hyp-
oxia there are much higher levels of HIF in the cell, the oxy-
gen-dependent hydroxylation and degradation machinery must
increase its capacity to cope with the degradation of the in-
creased protein mass. Third, HIF is also induced by a variety
of stimuli under normoxic conditions. How can HIF protein
stabilization occur in the presence of active PHDs and suffi-
cient oxygen supply? A plausible explanation lies in the lim-
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FIG. 4. Regulation of PHD function by gallate. The effects of gallic acid (A) and n-propyl gallate (B) on PHD1, PHD2,
and PHD3 (from left to right) hydroxylation activity were estimated in microtiter plate-based VBC binding assays. (C) CHO
cells stably transfected with a HIF-dependent luciferase reporter gene were treated with the indicated concentrations of n-propyl
gallate for 24 h. Relative light units (RLU) were normalized to the protein content of the lysates. Mean values  SEM of rep-
resentative experiments performed in triplicate (quadruplicates for the reporter gene assays) are shown.
ited expression levels of PHDs which are finely counterbal-
anced by HIF levels. If either one is upregulated, it overcomes
the function of the other. Thus, as well as an increase in PHD
synthesis leads to HIF degradation, an increase in HIF syn-
thesis leads to its stabilization even under normoxic conditions.
We have previously demonstrated that these mechanisms work
even under hypoxic conditions, since PHD-dependent HIF hy-
droxylation was reduced but still functional in direct proportion
to the decrease in available oxygen (50).
Regulation of the three PHD oxygen sensors by
small molecules
In this work, we have analyzed the effects of several small
molecules on PHD function in vitro. Addition of ferrous iron
was essential for PHD activity. Hirsilä et al. reported iron 
Km values for PHD1, PHD2, and PHD3 of 30, 30, and 100 nM,
respectively (18), and McNeill et al. reported a ferrous iron
binding constant of highly purified PHD2 of 1 M (36).
Our data support an increased iron affinity of PHD3 that reached
maximal activity already in the presence of 1 M FeSO4,
whereas PHD1 and PHD2 required 10 M FeSO4 for full ac-
tivity. The iron chelator desferrioxamine efficiently inhibited
PHD1 and PHD3 activity at concentrations corresponding to
the iron concentrations in the reaction buffer. PHD2 inhibition
was somewhat less efficient, but a drop in activity was observed
with similar desferrioxamine concentrations. Interestingly, it
has previously been suggested that desferrioxamine ineffi-
ciently inhibited crude PHD enzymes in vitro: in the presence
of 5 M Fe2 up to 1 mM desferrioxamine inhibited crude
PHDs by 20%, whereas inhibition of pure PHDs was much
more efficient (18). Thus, the efficiency of inhibition of the
PHDs by desferrioxamine might allow us to draw some con-
clusions on the purity of the enzyme preparation.
We previously determined an iron concentration in the FCS
of 148 M and in the cell culture medium of 16 M (56). The
intracellular concentration of chelatable iron has been reported
to be 3–6 M, depending on the cell type (45). Thus, the esti-
mated concentration of “free” iron for optimal PHD activity in
vitro corresponds to the iron concentrations in vivo, suggesting
that iron availability is indeed able to regulate the HIF system
by influencing PHD activity. This assumption has been con-
firmed by experimentally changing the “labile iron pool” in can-
cer cells (22, 24, 25). Interestingly, important iron uptake and
transport proteins are among the targets of HIF-1 that might
function also as a regulator of iron homeostasis in addition to
oxygen homeostasis (58). These values also explain why ~100
M of the hexadentate extracellular iron chelator desferriox-
amine but only ~10 M of the bidentate intracellular iron chela-
tor cyclopirox olamine were required to induce the HIF system
by inhibiting PHD activity (29).
Krebs cycle intermediates such as succinate and fumarate are
known to induce the HIF system by inhibiting PHD activity
(20, 43, 48). Moreover, 2-oxoacids such as pyruvate and ox-
aloacetate also induce HIF (12, 30). These findings link mi-
tochondrial function and cellular metabolism with the PHD/HIF
oxygen sensing system. Mutation of the tumor suppressor suc-
cinate dehydrogenase has been reported to increase cellular suc-
cinate concentration from 120 to ~440 M (48). The IC50 val-
ues for succinate have been reported to be in the range of
510–830 M for purified PHDs (26). We obtained similar IC50
values (~600 M) for succinate when the assays were per-
formed in the presence of 50 M 2-oxoglutarate. Succinate
competes for 2-oxoglutarate binding to the PHDs (16, 26), ex-
plaining why we observed only weak succinate inhibition of
PHD activity in the presence of high (500 M) 2-oxoglutarate
concentrations.
We demonstrated that ascorbate is essential for the function
of all three PHDs. It has been shown that physiological con-
centrations (25 M) of ascorbate suppress HIF-1 protein lev-
els in cancer cells, suggesting that intracellular ascorbate con-
centrations indeed respresent a major regulator of PHD function
(25). Ascorbate depeletion thus could also explain how transi-
tion metals induce HIF-1. Interestingly, Salnikow and col-
leagues reported that cellular ascorbate depletion causes NiSO4
and CoCl2 induced HIF-1 stabilization (23, 46). However, the
authors attributed this effect to inhibition of cellular ascorbate
uptake. Moreover, we could not observe any relevant nickel-
or cobalt-mediated degradation of ascorbate in vitro. In con-
trast, we observed a rapid copper-mediated ascorbate oxidation
which most likely explains the previously reported CuCl2-in-
duced HIF-1 stabilization via PHD inhibition in cultured cells
(32).
We have found that the antioxidant compounds gallic acid
and n-propyl gallate efficiently inhibited all three PHDs in vitro
and the esterified gallate also induced a HIF-dependent reporter
gene in cell culture. Tsukiyama et al. hypothesized that two
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FIG. 5. Regulation of PHD-dependent oxygen sensing.
Upon a hypoxic insult, the HIF-dependent transcriptional in-
crease of PHD2 and PHD3 levels provides a negative feedback
mechanism that defines a novel, adapted oxygen sensing set-
point capable of reacting to a second hypoxic insult. Small mol-
ecules contribute to the regulated oxygen sensing by triggering
PHD function, leading to an inverse regulation of the HIF lev-
els (for details see text).
phenolate oxygen atoms of gallate chelate with the active cen-
ter iron and the carboxyl group of gallate forms a strong
ionic/hydrogen bonding with Arg383 of PHD2 (53). In the
hands of these authors, n-propyl gallate was effective only in
cell culture but not in cell-free PHD assays, which was attrib-
uted to the esterified carboxyl group of n-propyl gallate. How-
ever, in our hands n-propyl gallate was even more efficient in
PHD inhibition in vitro than gallic acid. A likely reason for this
discrepancy was the use of crude cell lysates in a 2-oxoglu-
tarate conversion assay by these authors. We recently found that
2-oxoglutarate turnover using crude lysates is independent of
PHD function (Wirthner R. et al., unpublished observations).
What might be the mechanism of PHD inhibition by gallate-
containing antioxidants in comparison to other antioxidants
such as N-acetyl-L-cysteine? The use of molecular dioxygen for
oxidative decarboxylation-coupled protein hydroxylation re-
quires short-lived, highly reactive transition states of oxygen.
Antioxidants fitting into the active center of PHDs might scav-
enge these ROS, thereby blocking the PHD reaction cycle. Sim-
ilarly, exogenously produced ROS potentially could interfere
with these reactive transition states of oxygen. It has been sug-
gested that the increase in ROS content in junD/ or mucin 1
(MUC1) knock-down cells leads to a decrease in PHD activity
and hence to HIF-1 accumulation (15, 59). Thus, antioxidants
paradoxically would have the potential to do both: protect PHD
function from exogenous ROS and block PHD activity by de-
struction of PHD-inherent ROS intermediates. The effective
function of a given antioxidant would depend on the accessi-
bility to the active center, interference with transition metals
and ascorbate, and the scavenging efficiency of mitochondrial
and/or NADPH oxidase-derived ROS.
Regulation of the PHD oxygen sensors 
by other mechanisms
Up to date, only few reports deal with the regulation of PHDs
by protein–protein interactions. The E3 ubiquitin ligase Siah2
regulates PHD1 and PHD3, but not PHD2, protein stability (39).
PHD3, but not PHD1 or PHD2, appears to be a substrate for
the TRiC chaperonin (34). OS-9 apparently is simultaneously
interacting with both HIF and PHD2 or PHD3, but not PHD1,
thereby enhancing HIF hydroxylation and degradation (4). Mi-
togen-activated protein kinase organizer 1 (MORG 1) might
provide the molecular scaffold for HIF interaction specifically
with PHD3 (19). Finally, we recently reported that FKBP38
specifically regulates the stability of PHD2 (5). These exam-
ples demonstrate two things: first, abundance and function of
PHDs can also be regulated by specific proteins; and second,
the three different PHDs are regulated in nonidentical ways,
further supporting their nonredundant role in oxygen sensing.
While the cell-free in vitro assay used in this work provides
useful information on the regulated function of each PHD in-
dividually, it can of course not take into account the manifold
additional modes of PHD regulation, (e.g., by protein–protein
interaction), found within a cell.
PHD2 and PHD3, but not PHD1 or FIH, are transcriptionally
induced under hypoxic conditions (3, 6, 8, 11, 13, 14, 33). It
could be shown that HIF is required for hypoxic induction of
PHD2 and PHD3 gene expression, and hypoxia response ele-
ments were identified in the regulatory regions of the corre-
sponding genes (37, 42). Because the essential cofactor oxygen
is basically lacking under hypoxic conditions, the HIF-dependent
hypoxic increase in PHD abundance is somewhat paradoxical. It
has been suggested that increased PHD levels accelerate the ter-
mination of the HIF response following reoxygenation (2, 3, 14,
33). Indeed, biochemical in vitro studies revealed Km values of
purified PHDs for oxygen close to the pO2 in air, suggesting that
the kinetics of specific HIF hydroxylation under hypoxic con-
ditions are rather slow (17). However, tissues in situ have to deal
with a great variability of generally very low pO2 values, even
when the inspiratory pO2 is considered to be “normoxic”. Thus,
the PHD oxygen sensors need to operate at different pO2 setpoint
values in different tissues. We recently demonstrated that a self-
regulatory loop defines a specific threshold for HIF-activation
as a function of the actual pO2 (50). As schematically outlined
in Fig. 5, this negative feedback-loop includes: (a) a HIF-de-
pendent induction of PHD2 and PHD3 upon a reduction in oxy-
gen supply; (b) a PHD-dependent, partial reduction of HIF even
under very low pO2; (c) the subsequent partial reduction of the
PHD2 and PHD3 levels; (d) the definition of a novel setpoint for
oxygen sensing by leveling off the HIF/PHD ratio; (e) a sec-
ondary response to a further, more severe hypoxic insult; and (f)
the triggering by iron, ascorbate, Krebs cycle intermediates, ROS,
and antioxidants. Small molecule regulators of PHD activity are
thus functionally relevant under normoxic as well as hypoxic con-
ditions.
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Vitamin C is dispensable for oxygen sensing in vivo
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Prolyl-4-hydroxylation is necessary for
proper structural assembly of collagens
and oxygen-dependent protein stability
of hypoxia-inducible transcription factors
(HIFs). In vitro function of HIF prolyl-4-
hydroxylase domain (PHD) enzymes re-
quires oxygen and 2-oxoglutarate as co-
substrates with iron(II) and vitamin C
serving as cofactors. Although vitamin C
deficiency is known to cause the collagen-
disassembly disease scurvy, it is unclear
whether cellular oxygen sensing is simi-
larly affected. Here, we report that vitamin
C–deprived Gulo/ knockout mice show
normal HIF-dependent gene expression.
The systemic response of Gulo/ ani-
mals to inspiratory hypoxia, as measured
by plasma erythropoietin levels, was simi-
lar to that of animals supplemented with
vitamin C. Hypoxic HIF induction was
also essentially normal under serum- and
vitamin C–free cell-culture conditions,
suggesting that vitamin C is not required
for oxygen sensing in vivo. Glutathione
was found to fully substitute for vitamin C
requirement of all 3 PHD isoforms in vitro.
Consistently, glutathione also reduced
HIF-1 protein levels, transactivation ac-
tivity, and endogenous target gene ex-
pression in cells exposed to CoCl2. A
Cys201Ser mutation in PHD2 increased
basal hydroxylation rates and conferred
resistance to oxidative damage in vitro,
suggesting that this surface-accessible
PHD2 cysteine residue is a target of anti-
oxidative protection by vitamin C and
glutathione. (Blood. 2011;117(20):
5485-5493)
Introduction
Oxygen is essential for several physiologic processes, particularly
for cellular respiration and energy metabolism. On the molecular
level, response to hypoxia is mediated by hypoxia-inducible transcrip-
tion factors (HIFs). Under continuous oxygen supply, 2 distinct prolyl
residues within the oxygen-dependent degradation domain of HIF
subunits are hydroxylated by prolyl-4-hydroxylase domain–containing
enzymes (PHDs). Hydroxy-HIF is recognized by the von Hippel–
Lindau tumor suppressor protein (pVHL) and subsequently targeted for
proteasomal degradation.1,2 When oxygen is limited, PHD activity
ceases, and nonhydroxylated HIF is stabilized and heterodimerizes
with the HIF subunit to activate expression of numerous target
genes.3 Moreover, an asparaginyl hydroxylase termed factor-
inhibiting HIF hydroxylates a C-terminal Asn residue of HIF
subunits in an oxygen-dependent manner, thereby regulating
cofactor recruitment and HIFs’ transcriptional activity.4
Three PHD isoforms have been characterized so far, termed
PHD1, PHD2, and PHD3; they differ in size, subcellular localiza-
tion, and tissue distribution.5 PHD2 is the most ubiquitously
expressed isoform, responsible for the normoxic control of HIF.6
Accordingly, genetic ablation of PHD2 but not PHD1 or PHD3
results in embryonic lethality in mice.7 Suggesting a fundamental
role in the hematopoietic and circulatory systems, somatic inactiva-
tion of PHD2 leads to increased erythropoiesis and angiogenesis as
a result of HIF stabilization followed by activation of its target
genes, including erythropoietin (EPO) and vascular endothelial
growth factor.8 Knockout of either PHD1 or PHD3 had no effect on
hematologic parameters. However, combined PHD1/PHD3 knock-
out animals showed a slight increase in hematocrit, hemoglobin,
and red blood cell counts.9 Clinical data on patients with erythrocy-
tosis revealed Pro317Arg or Arg371His mutations in the gene
encoding for PHD2, altering the hydroxylation efficiency of the
mutant protein.10,11 A third point mutation in PHD2 (His374Arg)
was found in a patient suffering from erythrocytosis and paragan-
glioma.12 These case reports emphasize the critical role of PHD2 in
regulating erythropoiesis and maintaining red blood cell homeosta-
sis in humans.
PHDs belong to a larger superfamily of 2-oxoglutarate and
Fe(II)-dependent dioxygenases. Similar to collagen prolyl-4-
hydroxylase ([C-P4H]; EC 1.14.11.2), PHDs require molecular
oxygen and 2-oxoglutarate as cosubstrates, as well as ferrous iron
and probably L-ascorbic acid (vitamin C) as cofactors for enzy-
matic activity.13 Km values of PHDs for oxygen are strikingly
higher than those of other prolyl-4-hydroxylases.13 The relatively
low oxygen affinity is essential for effective oxygen sensing,
because even small changes in oxygen partial pressure can
influence hydroxylation activity.13-15
In a previous study, we reported on the dose-dependent
regulation of the in vitro activity of all 3 PHD isoforms by their
essential cosubstrates and cofactors, including vitamin C.16 Pri-
mates, including humans, lost the ability to synthesize vitamin C de
novo and thus depend on dietary vitamin C intake. C-P4Hs
hydroxylate proline residues to stabilize the collagen triple helix
structure. Because ascorbate is an essential cofactor for C-P4Hs,
persistent ascorbate deficiency results in disassembly of connective
tissue structures, a common symptom of the nowadays rare disease
scurvy.17 With Km values ranging from 140 to 180M, the
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requirement of PHDs for vitamin C in vitro is only 2-fold lower
than for C-P4H, suggesting that HIF hydroxylases also could well
be affected by vitamin C malnutrition.13 Mice lacking a functional
Gulo gene have been described as a model to study vitamin C
deficiency.18 Gulo encodes for l-gulono-1,4-lactone-oxidase (EC
1.1.3.8), a key enzyme involved in the final step of vitamin C
biosynthesis. Dietary vitamin C deprivation leads to body weight
loss, anemia, aortic wall damage, and internal hemorrhages in these
mice.18
Although the interaction between the target prolyl residue,
molecular oxygen, 2-oxoglutarate, and iron during the reaction
cycle in the active center of PHDs has been described in detail
previously, the apparently inevitable presence of vitamin C for the
in vitro function of the PHDs remains elusive.19,20 Because of its
antioxidative properties, vitamin C might maintain ferrous iron in
the reduced state. Given the enzymatic relationship between HIF
and C-P4Hs, we set out to investigate the effect of dietary vitamin
C on the regulation of the PHD-HIF oxygen–sensing pathway in
Gulo/ mice under normoxemic and hypoxemic conditions.
Methods
Cell culture
HeLa human cervix carcinoma cells were adapted to Ham nutrient mixture
F-12 (Sigma-Aldrich), free of ascorbate and fetal calf serum (FCS), containing
the following supplements: epidermal growth factor (50 ng/mL; Sigma-
Aldrich), insulin (5 g/mL; Sigma-Aldrich), apo-transferrin (5 g/mL;
Sigma-Aldrich), hydrocortisone (100nM; Sigma-Aldrich) buffered with
15mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid pH 7.4 as
well as 100 IU/mL penicillin and 100 g/mL streptomycin. HepG2 human
hepatoma cells stably transfected with a HIF-dependent firefly luciferase
reporter gene termed HRG1 have been described previously.21 If not
indicated otherwise, all cells were maintained in DMEM with 10% FCS,
100 IU/mL penicillin, and 100 g/mL streptomycin. Cell number and
viability were determined using a ViCell counter (Beckman Coulter).
HIF transactivation activity
HeLa cells (5  105) were cotransfected with 500 ng of the HIF-dependent
pH3SVL reporter vector containing 6 HIF binding sites in total derived
from regulatory elements of the transferrin gene22 and 40 ng of pRL-CMV
Renilla luciferase expression plasmid (Promega) essentially as described
previously.14 Twenty-four hours after transfection, cells were split and
exposed to graded oxygen concentrations (21%-0.2% oxygen) for 24 hours
by using cross-calibrated oxygen-controlled CO2 incubators (CB 150;
Binder). Stably transfected HRG1 HIF reporter cells were adapted to 1%
FCS overnight and treated with 50M desferrioxamine mesylate (Dfx;
Sigma-Aldrich) or 100M CoCl2 and 1 to 10mM reduced l--glutamyl-l-
cysteinyl-glycine ([GSH] 250mM stock solution adjusted to pH 7.0) or
0.2 to 2mM ascorbate for 24 hours. For hypoxic experiments, cells were
grown under 2% O2 for 24 hours and treated with GSH or ascorbate. HRG1
cells were transfected with pRL-SV40 Renilla luciferase to control for
non–HIF-mediated effects of ascorbate and GSH on the heterologous
simian virus 40 minimal promoter present in both constructs. Cells were
lysed using passive lysis buffer, and luciferase activities were determined
according to the manufacturer’s instructions (Promega) by using a 96-well
luminometer (Berthold Technologies). Data are expressed as relative
luciferase activities per total cellular protein of experiments performed in
triplicates by calculating the ratio of firefly/Renilla activities per well.
Expression and purification of recombinant PHD enzymes
Recombinant PHD proteins were expressed and purified as glutathione
transferase (GST)–fusion proteins from baculovirus-infected Sf9 insect
cells as described previously.14 Untagged enzyme preparations were
obtained by introducing a PreScission protease cleavage site between the
GST-tag and the PHD open reading frame. A Cys201Ser point mutation was
introduced into the human PHD2 expression plasmid by site-directed
mutagenesis (Stratagene). Untagged PHD2 was expressed in Sf9 cells and
purified by conventional ion-exchange chromatography (kind gift of Dr
Felix Oehme, Bayer Healthcare, Wuppertal, Germany). Purity of the
enzyme preparations was analyzed by sodium dodecyl sulfate–polyacrylam-
ide gel electrophoresis followed by Coomassie staining or immunoblotting.
Prolyl-4-hydroxylation assay
Activity of recombinant PHD enzymes was measured by a microtiter
plate-based peptide hydroxylation assay as described previously.23 In brief,
recombinant PHDs were used to hydroxylate a biotinylated peptide derived
from HIF-1 (amino acid residues 556-574) coupled to streptavidin-coated
96-well plates. Hydroxylation reaction was performed for 1 hour at room
temperature in the presence of 10M FeSO4, 0.5mM 2-oxoglutarate, and
2mM ascorbate in 20mM Tris-HCl pH 7.5, 5mM KCl, and 1.5mM MgCl2.
Hydroxylated peptides were detected by recombinant, thioredoxin-tagged
von Hippel–Lindau/elongin B/elongin C (VBC) complex. Reactions were
stopped by removing the reaction mix and adding 1mM H2O2. Bound VBC
complex was detected by rabbit anti-thioredoxin antibodies and secondary
horseradish peroxidase (HRP)–conjugated anti-rabbit antibodies (Sigma-
Aldrich) by using the 3,3,5,5-tetramethylbenzidine substrate kit (Pierce).
The peroxidase reaction was stopped by adding 2M H2SO4, and absorbance
was determined at 450 nm in a microplate reader. Background values as
determined by using a mutant HIF-1 (Pro564Ala) peptide were subtracted
for each experiment.
Ascorbate determination
Ascorbate content of in vitro hydroxylation assay samples was quantified
by high-performance liquid chromatography (HPLC) as described previ-
ously.24 In brief, a 10-fold dilution of the enzyme reaction mix containing
2mM ascorbate was analyzed before and after 1 hour of hydroxylation
reaction. After dilution in the mobile phase (60mM phosphoric acid,
pH 3.1), a 20-L sample was injected onto a Nucleosil C18 column
(Macherey Nagel) and eluted applying an acetonitrile gradient (0%-60%).
Ascorbate elution was monitored at 254 nm, corresponding to 96%
absorbance of ascorbate and only 4% of dehydroascorbate.25 Chromato-
grams and standard curve of pure ascorbate ranging from 25 to 200M
were used to calculate the content of ascorbate in study samples (supplemen-
tal Figure 2, available on the Blood Web site; see the Supplemental
Materials link at the top of the online article). Ascorbate levels in plasma
samples of mice were determined by HPLC (Swiss Vitamin Institute).
Immunoblot analyses
Total soluble cellular proteins were extracted with a high salt extraction
buffer containing 0.4M NaCl, 0.1% Nonidet P-40, 10mM Tris-HCl pH 8.0,
1mM ethylenediaminetetraacetic acid, 1mM dithiothreitol, 1mM phenyl-
methylsulfonyl fluoride, and protease inhibitor cocktail (Sigma-Aldrich).
Protein concentration was measured by the method of Bradford, and 60 to
70 g of cellular protein was subjected to immunoblot analyses. Mem-
branes were probed using the following dilutions of mouse monoclonal
(mAb) or rabbit polyclonal antibodies: mAb anti–HIF-1 (1:1000; BD
Transduction Laboratories), mAb anti-CA9 (M75; kindly provided by
S. Pastorekova, Bratislava, Slovak Republic), mAb anti–-actin (1:5000;
Sigma-Aldrich), rabbit anti-PHD1 (1:2000; Genway), rabbit anti-PHD2
(1:1000; Novus), or rabbit anti-PHD3 (1:1000; Novus), followed by
secondary HRP-conjugated antibodies (1:2000; all Pierce).
mRNA quantification
Total RNA purification and mRNA determination by real-time PCR has
been described previously.14 Transcript levels of the HIF-dependent and
-independent genes were quantified by reverse transcription (RT) quantita-
tive (q) PCR using SYBR Green qPCR reagent kit (Sigma-Aldrich) in
combination with an MX3000P light cycler (Stratagene). Initial copy
number of each sample was calculated by comparison with serial dilutions
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of a calibrated standard. For mouse tissues, ribosomal protein S12 mRNA
was used as a housekeeping gene, and ribosomal protein L28 mRNA served
as control for samples from human cell lines. Primer sequences are given in
supplemental Table 1.
OxyBlot detection of protein oxidation
PHD2 carbonylation was determined with a protein oxidation detection
kit (OxyBlot; Millipore). In brief, 50 ng/L recombinant PHD2 was
exposed to either 100M CoCl2, 10M FeSO4, 2mM ascorbate, 0.5mM
2-oxoglutarate, or 1mM H2O2 in the presence of 400nM wild-type or
Pro564Ala mutant HIF-1 peptide in 20mM Tris–HCl, 5mM KCl, and
1.5mM MgCl2 for 1 hour at room temperature. Then, 5 L of the
reaction mix was mixed with 5 L of 12% sodium dodecyl sulfate, and
the carbonyl groups were derivatized with 10mM 2,4-dinitrophenylhy-
drazine for 15 minutes. Dinitrophenyl groups were detected by immuno-
blotting using rabbit anti-DNP antibodies (1:150) followed by secondary
goat anti–rabbit HRP-conjugated antibodies (1:300). For loading con-
trols, PHD2 was detected using rabbit anti-PHD2 antibodies (Novus).
Animal studies
Gulo/ mice were maintained on vitamin C–supplemented water contain-
ing 0.33 g/L L-ascorbic acid and 0.01mM EDTA as described previously.18
At 3 months of age, ascorbic acid supplement was withdrawn from
6 Gulo/ males but continued for the control males. After 5 weeks, mice
were killed with an overdose of 2,2,2-tribromoethanol, and tissues were
collected and stored in RNAlater (Applied Biosystems) at20°C until use.
For hypoxia studies, 22 Gulo/ males with an average age of 16 weeks
were allocated to 4 groups so that no significant differences were observed
in mean body weight and age of the animals at the beginning of the
experiment. The body weight was determined every second day. After
36 days of ascorbate withdrawal, mice were exposed to 8% oxygen for
24 hours in a hypoxia tent (Coy Laboratory Products). Control animals
were maintained at ambient oxygen concentration. Heparinized whole
blood was collected from all mice by cardiac puncture after intraperitoneal
injection anesthesia using 4 mg/mL xylazine and 20 mg/mL ketamine at a
dosage of 0.1 mL/20 g body weight. Blood samples of hypoxic animals
were collected inside the hypoxic tent. Animal experiments were conducted
at 2 centers with the appropriate consent by the Institutional Animal Care
and Use Committees of the University of North Carolina at Chapel Hill for
breeding and normoxic gene expression studies or by the Veterinary Office
of the Canton Zu¨rich (119/2010) for hypoxia studies.
Blood parameters and plasma EPO concentrations
Plasma EPO levels were measured by enzyme-linked immunosorbent assay
following the procedures recommended by the manufacturer (Quantikine;
R&D Systems). EPO concentrations were determined by comparison with a
calibrated recombinant mouse EPO standard. Hematologic parameters of
mouse whole blood were analyzed by the Division of Hematology
(University Hospital, Zu¨rich, Switzerland).
Results
Ascorbate is not required for HIF induction by hypoxia in
HeLa cells
HeLa cells have been described previously to grow in serum-free
medium supplemented with hormones and growth factors.26 To
achieve cell culture conditions avoiding ascorbate contamination
derived from animal sera, HeLa cells were adapted to a chemically
defined medium free of ascorbate for at least 2 weeks. Control cells
were grown in the same medium supplemented with 50M
ascorbate. Both cell groups proliferated at the same rate with no
differences noticed between ascorbate-free and supplemented cells
(Figure 1A). Despite its need for PHD activity in vitro, hypoxic
HIF-1 protein accumulation was similar in ascorbate-containing
and -deficient cells. However, a faint normoxic induction of
HIF-1 could be observed in ascorbate-free cells only (Figure 1B).
Accordingly, cells transfected with a HIF-responsive reporter gene
(pH3SVL) and subsequently exposed to graded oxygen concentra-
tions (0.2%, 1%, 3%, or 21% O2, respectively) revealed similar
induction levels of luciferase activity under both culture conditions
(Figure 1C).
GSH can substitute for vitamin C in the hydroxylation reaction
catalyzed by PHDs
Because HeLa cells grown in a medium containing no ascorbate
maintained hypoxic HIF-1 stabilization, we speculated that other
antioxidants could compensate for vitamin C loss in these cells.
Thus, several compounds with antioxidative properties were tested
for their effects on PHD hydroxylation activity by using a
previously described in vitro hydroxylation assay.23 Surprisingly,
some compounds such as n-propyl gallate16 and the superoxide
dismutase mimetic Mn(III) tetrakis(1-methyl-4-pyridyl)porphyrin
pentachloride were potent inhibitors of PHD enzymes (supplemen-
tal Figure 1A). However, GSH enhanced HIF hydroxylation by
all 3 PHDs. Because the recombinant enzyme preparations in the
initial experiments were expressed and purified as GST-fusion
proteins, we could not exclude interference of the tested antioxi-
dants, particularly GSH, with the GST-tag. Therefore, a PreScis-
sion protease cleavage site was engineered in between the 2 fusion
partners. Chimeric GST.PHD and tag-free PHD enzymes showed
comparable hydroxylation activity (supplemental Figure 1B). GSH
Figure 1. Cellular oxygen sensing by the PHD-HIF pathway does not require
vitamin C. (A) Proliferation of HeLa cells growing in FCS-free, chemically defined
medium containing either no or 50M ascorbate. (B) Stabilization of HIF-1 protein in
HeLa cells maintained in FCS-free medium containing either no (Asc.) or 50M
ascorbate. Cells were exposed to 21% and 0.2% oxygen for 6 hours, and then protein
levels were analyzed by immunoblotting. (C) Induction of HIF-dependent luciferase
activity (pH3SVL vector) in HeLa cells maintained in FCS-free medium containing
either no or 50M ascorbate and exposed to 0.2% to 21% oxygen for 24 hours.
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increased the activity of all 3 untagged PHD isoforms, even in the
absence of ascorbate (Figure 2A). Addition of GSH ( 5mM in
Figure 2B) to 2mM ascorbate increased the reaction rate compared
with ascorbate alone (control in Figure 2B), suggesting 2 indepen-
dent reaction modes of GSH, one mode replacing vitamin C and an
additional mode enhancing the reaction rate. Of note, only minor
changes in ascorbate oxidation were found before and after 1 hour
of PHD2-mediated substrate hydroxylation (Figure 2C). The minor
decrease in reduced ascorbate was probably because of air-
dependent oxidation rather than enzymatic consumption because it
was independent of the presence of the hydroxyl-acceptor substrate
(Figure 2C right panel). In conclusion, as shown previously for
C-P4H,27 ascorbate is not consumed during coupled PHD-
catalyzed hydroxylation reactions.
GSH decreases HIF activity in CoCl2-treated hepatoma cells
In cell culture models, Co(II) and Ni(II) have been shown to
substantially decrease cellular ascorbate content by catalyzing
ascorbate oxidation to dehydroascorbate followed by irreversible
hydrolysis to diketogulonate.28 Interestingly, exogenous ascorbate
administration completely blunted the Co(II)-induced hypoxic
response in lung epithelial cells.29 To test whether GSH could
similarly compensate for reduced ascorbate levels after Co(II)
stimulation, HIF transcriptional activity was further studied in
HepG2 hepatoma cells stably transfected with an HIF-dependent
luciferase reporter gene (HRG1 cells). We first determined the
concentrations of CoCl2 required to activate HIF-dependent re-
porter gene expression to a similar extent as exposure of the cells to
2% oxygen or the hypoxia mimicking iron chelator Dfx (Figure
3A). Subsequently, HRG1 cells were treated with 100M CoCl2 or
50M Dfx under 21% or 2% oxygen. Control cells were kept at
Figure 3. GSH impairs HIF activation in cells. (A) Induction of HIF-dependent
luciferase reporter gene activity in stably transfected HRG1 hepatoma cells by 2%
O2, 50M Dfx, or 100M CoCl2 for 24 hours. (B) Effects of ascorbate (Asc, 0.2-2mM;
top panel) or GSH (1-10mM; bottom panel) in combination with hypoxia, Dfx, or CoCl2
treatment on HIF-dependent luciferase activity relative to the protein concentration of
the lysates. Shown are mean values 	 SEM of 3 independent experiments
normalized to the reporter activity in the absence of either ascorbate or GSH
(control). (C) CA9 and NDRG1 HIF target gene mRNA levels in HRG1 cells after
treatment with 2mM ascorbate or 10mM GSH combined with 2% O2 or 100M
CoCl2 for 24 hours. Shown are mean values 	 SEM of 3 independent experi-
ments relative to the mRNA content of ribosomal protein L28. (D) HIF-1 and
CA9 protein levels in HRG1 cells after treatment with 2mM ascorbate or 10mM
GSH combined with 2% O2 or 100M CoCl2. (E) OxyBlot analyses of recombinant
PHD2 protein carbonylation. GSH (5mM) reduced PHD2 carbonylation by either
2mM ascorbate/10M FeSO4 or 100M CoCl2 (left panel). PHD2 oxidation is
independent of target hydroxylation as shown by using a wild-type or a Pro564Ala
mutant HIF-1 hydroxyl-proline acceptor peptide in in vitro hydroxylation reac-
tions (right panel).
Figure 2. GSH substitutes for vitamin C as a cofactor in HIF-1 hydroxylation in
vitro. (A) GSH can enhance PHD hydroxylation activity in the absence of ascorbate
(Asc.) in a dose-dependent manner. Hydroxylation activity was determined using a
multiwell VBC binding assay. (B) PHD-dependent hydroxylation reaction rate in the
presence of 2mM ascorbate (control) or 2mM ascorbate combined with 5mM GSH
(5mM GSH). Shown are mean values 	 SEM of triplicates. (C) Ascorbate determi-
nation by HPLC before and after 1 hour of PHD2-dependent hydroxylation reaction
(left panels). Ascorbate content is only slightly decreased after 1 hour of incubation
and independent of target hydroxylation (right panel). Shown are mean values	 SEM of
3 independent experiments normalized to values measured at time point zero.
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ambient oxygen concentrations. All cells were cotreated with 1 to
10mM GSH or 0.2 to 2mM ascorbate. Indeed, ascorbate and GSH
reduced HIF activity exclusively in CoCl2-treated HRG1 cells
(Figure 3B). A substantial increase of HIF activation was noted
particularly when cells were treated with 2mM ascorbate, which
might be explained by the pro-oxidative function ascorbate exerts
if applied at high concentration (Figure 3B top panel).30 In line
with these observations, both ascorbate and GSH reduced the
expression levels of the endogenous HIF target genes CA9 and
NDRG13 only in cells treated with CoCl2, whereas 2mM
ascorbate enhanced hypoxic activation of both genes by almost
2-fold (Figure 3C). To evaluate whether these effects reflected
differential activities of cellular PHD enzymes, HIF-1 protein
accumulation was analyzed by immunoblotting. As expected,
only CoCl2-stabilized HIF-1 was down-regulated by cotreat-
ment with ascorbate or GSH (Figure 3D). Interestingly, 10mM
GSH was a more potent inhibitor of CoCl2-induced HIF-1
stabilization than 2mM ascorbate, a concentration that showed
saturated inhibition of the HIF-reporter in the same cell line
(Figure 3B top panel).
GSH protects PHD2 from metal-catalyzed oxidation
Enzymatic activity of the PHDs is sensitive to reactive oxygen
species and transition metal ions.31 However, the mechanism(s) by
which reactive oxygen species or metal ions inhibit hydroxylase
activity remained speculative. Besides its general antioxidative
properties as radical scavenger, vitamin C actively interferes with
the oxidation state of metal ions by serving as electron donor in a
redox reaction. As such, it largely differs from GSH that is a major
cellular antioxidant protecting cysteinyl and methionyl residues in
proteins from oxidative modifications. Both CoCl2 and H2O2
inhibited all 3 PHD isoforms in vitro, with PHD2 being slightly
more resistant to CoCl2 (supplemental Figure 3). To directly
determine protein oxidation by these compounds, carbonyl group
formation in PHD2 was estimated by OxyBlot technology. As
shown in Figure 3E (left panel), 2mM ascorbate and 10M FeSO4
(as used in the standard reaction buffer for in vitro hydroxylation)
substantially increased carbonylation of recombinant PHD2 during
1 hour of hydroxylation reaction. Surprisingly, CoCl2 increased
carbonylation of PHD2 whether ascorbate/FeSO4 was present or
not. After addition of 5mM GSH, oxidation of PHD2 by ascorbate/
FeSO4, CoCl2, and H2O2 was markedly reduced. To examine
whether PHD2 protein oxidation is coupled to its dioxygenase
activity, the reaction was performed in the presence of a mutant
Pro564Ala HIF-1 peptide substrate. As shown in Figure 3E
(right panel), PHD2 protein oxidation was independent of the
presence of a hydroxylation acceptor proline, providing evi-
dence that protein oxidation is not caused by the hydroxylation
reaction cycle.
Cysteine 201 affects PHD2 hydroxylation activity
Recently, cysteine residue 201 within the catalytic domain of
PHD2 has been identified as a surface-accessible, highly nucleo-
philic residue predominantly interacting with thiol compounds.32
Moreover, Cys201 and Cys208 were proposed to provide an
additional metal binding site in PHD2.33 Both, Cys201 and Cys208
are highly conserved among all 3 human and mouse PHD
isoforms (Figure 4A). To investigate the functional relevance of
Cys201, recombinant PHD2, wild type, or Cys201Ser mutant
was purified from Sf9 cells. Surprisingly, the Cys201Ser
mutation significantly (P 
 .0001) increased the PHD2 reaction
rate by 2.5-fold (Figure 4B top panel). Equal concentrations of
wild-type and mutant PHD2 proteins were confirmed by Coomas-
sie staining of the undiluted stock solutions and immunoblotting
of the diluted assay solutions (Figure 4B bottom panel). To
further test the hypothesis that the Cys201Ser mutation might
protect the PHD2 enzyme from oxidative damage, the effect of
H2O2 on hydroxylation activity was measured. As shown in
Figure 4C, the half-maximal inhibitory concentration for H2O2
was roughly 5-fold higher for the Cys201Ser mutant compared
with wild-type PHD2 (half-maximal inhibitory concentration of
8.9  106 and 4.3  105 M H2O2 for wild-type and Cys201Ser
mutant PHD2, respectively). We further tested whether the
H2O2-mediated loss of PHD2 activity could be rescued by
sequential addition of GSH. For both enzyme preparations,
Figure 4. A Cys201Ser mutation enhances PHD2-dependent hydroxylation
reaction rate and protects from protein oxidation. (A) Conservation of cysteine
residues (Cys201 and Cys208 in human PHD2) in all 3 human (Hs) and mouse (Mm)
PHD isoforms. (B) Increased reaction rate of Cys201Ser mutant PHD2 as measured
by the hydroxylation-dependent VBC binding assay. Shown are mean values 	 SEM
of 3 independent experiments. Linear regression analyses were performed, revealing
highly different slopes (P 
 .0001). (C) The Cys201Ser mutation confers resistance
of PHD2 to H2O2-mediated inhibition of hydroxylation activity. Shown are mean
values 	 SEM of a representative experiment performed in triplicates. (D) GSH can
rescue PHD2 wild type and Cys201Ser hydroxylation activities after H2O2-mediated
enzyme damage. In brief, enzyme preparations were preincubated with 1mM H2O2
for 30 minutes (H2O2) or left untreated for a similar period (control). For rescue
experiments, enzymes after H2O2 treatment were incubated with 5mM GSH
(H2O2  GSH) for 15 minutes. Hydroxylation reactions were carried out at standard
assay conditions for 60 minutes. Note that all reactions contained 2mM ascorbate
freshly added when hydroxylation reactions were started. Data are given as mean
values 	 SEM of 3 independent experiments normalized to hydroxylation activities of
control reactions obtained after 60 minutes.
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preincubation with 1mM H2O2 for 30 minutes inhibited subse-
quent substrate hydroxylation reactions, despite 2mM ascorbate
being freshly added to start the hydroxylation reaction
(Figure 4D). Interestingly, further addition of 5mM GSH could
similarly reactivate both enzyme preparations, although reaction
kinetics was substantially slower for the reactivated enzymes
(Figure 4D).
Oxygen sensing is fully functional in ascorbate-deficient
Gulo/ mice
Gulo/ mice received a diet with or without vitamin C for
5 weeks. Transcript levels of known HIF target genes (Bnip3, Ca9,
Glut1, Pdk1, Phd2, Phd3, and Ndrg1) as well as genes involved in
antioxidative defense (Sod1, Sod2, and Glrx), the ascorbate
transporters Svct1 and Svct2, or oxygen-independent genes (Ednrb,
Mmp3, and Phd1) were determined by RT-qPCR in brain, lung,
kidney, heart, and liver. Similar tissue-specific expression levels for
most genes involved in different pathways were observed in both
groups (Figure 5A). Conclusive with our finding from cell culture
experiments, expression levels of most of the HIF target genes
remained largely unaffected by vitamin C deficiency or even
showed reduced levels (blank and blue squares, respectively, in the
heatmap shown in Figure 5B). Expression of the ascorbate
transporter Svct1, however, was moderately induced in animals fed
without ascorbate, possibly reflecting compensatory mechanisms
for ascorbate deprivation.
To further test whether the absence of ascorbate limits PHD
function under hypoxic conditions, Gulo/ males were deprived
of vitamin C for 5 weeks, whereas control animals were supple-
mented with vitamin C. As described previously,18 the animals
developed a scorbutic phenotype marked by a substantial loss of
body weight after 35 days on a ascorbate-free diet, indicating that
systemic stores of vitamin C have been exhausted (Figure 5C left
panel). In line with this observation, plasma ascorbate levels in
Gulo/ mice fed an ascorbate-free diet were below the detection
limit ( 1M), whereas plasma of control animals contained 40.3
to 123.8M vitamin C (Figure 5C right panel), corresponding to
ascorbate plasma levels in healthy humans.34
After 5 weeks of vitamin C deprivation, mice were breathing
8% oxygen for an additional period of 24 hours, whereas control
groups were kept under ambient oxygen concentration (see scheme
in Figure 5C). Both ascorbate-deficient and supplemented animals
responded to the hypoxic treatment with a robust induction of Epo
mRNA in the kidney that was higher in Gulo/ males fed without
ascorbate, although differences did not reach the level of signifi-
cance (P  .07, Student t test; Figure 5D left panel). Circulating
EPO protein levels in mouse plasma were induced by hypoxic
exposure to a similar extent in both groups (Figure 5C right panel).
Figure 5. Hypoxic response is fully functional in vitamin C–depleted Gulo/
mice. Gulo/ male mice received a diet with (Asc) or without (Asc) ascorbate for
5 weeks. (A) Transcript levels of HIF target genes (Bnip3, Ca9, Glut1, Pdk1, Phd2,
Phd2, Phd3, and Ndrg1) as well as genes involved in antioxidative defense (Sod1,
Sod2, and Glrx), the ascorbate transporters Svct1 and Svct2, or oxygen-independent
genes (Ednrb, Mmp3, and Phd1) were quantified by RT-qPCR in brain, kidney, lung,
liver, and heart. Values are expressed relative to S12 mRNA levels and visualized
in a heatmap (Genepattern; Broad Institute). Lowest and highest mRNA levels of
Figure 5 (continued). each gene were arbitrarily defined as 3 (dark blue) and 3
(dark red), respectively. (B) Heatmap of gene expression changes following a vitamin
C–deficient diet. Log2 (Asc/Asc) ratios revealed that the majority of HIF target
genes remained either unchanged or showed a slightly reduced expression pattern.
Data ranged from 1.75 (dark blue) and 1.79 (dark red), respectively. (C) Scheme
depicting the experimental setup for hypoxic experiments with vitamin C–depleted
Gulo/ animals (top panel). Relative gain of body weight of Gulo/ mice (n  11
animals per group) after ascorbate withdrawal (Asc) or ascorbate supplementation
(Asc) for 36 days (left panel). Ascorbate levels in the plasma of Gulo/ mice (n  6
animals per group) after 5 weeks of ascorbate withdrawal compared with mice kept
on an ascorbate-supplemented diet (right panel). (D) Epo mRNA (left panel) and
circulating EPO protein (right panel) levels in Gulo/ mice maintained on a diet with
(Asc) or without (Asc) for 5 weeks followed by exposure to 8% or 21% oxygen for
24 hours. Data represent mean values 	 SEM derived from at least 5 animals per
group; n.s., indicates not significant.
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Of note, no significant changes of the red cell lineage hematologic
parameters were observed in Gulo/ mice after 5 weeks of
ascorbate depletion, indicating that the oxygen transport capacity
was similar in both treatment groups. Hypoxic increases in
hematocrit values are known to be delayed and reach the level of
significance not before 72 hours of continuous exposure to hyp-
oxia,35 explaining the lack of an increase of either hematocrit
values or red blood cell counts in our experimental setting with a
hypoxic period of only 24 hours (supplemental Table 2).
Discussion
Ascorbic acid and ferrous iron have been reported as essential
cofactors for PHD-dependent HIF hydroxylation in vitro.13
Unexpectedly, we found a fully functional cellular oxygen-sensing
pathway in HeLa cells maintained under strictly ascorbate-free
culture conditions, indicating that ascorbate is dispensable for
HIF hydroxylation in vivo. In a search for the nature of
antioxidative compounds substituting for ascorbate during prolyl-
4-hydroxylation, we identified GSH as a potent activator of all
3 PHDs in vitro, increasing HIF peptide hydroxylation in a
dose-dependent manner. Notably, ascorbate and GSH are the most
abundant reducing compounds within eukaryotic cells.36 Given the
distinct antioxidative properties of vitamin C and GSH, the
2 compounds might affect prolyl-4-hydroxylation by different
ways. Ascorbate might be required to reduce occasionally oxidized
ferric Fe(III) generated in the active center of PHDs by uncoupled
reaction cycles as it has been described for C-P4H.27 However, to
the best of our knowledge, no experimental evidence has been
reported for enzymatic activity of PHDs in the absence of a
hydroxyl-acceptor substrate. Strikingly, the major iron form bound
to purified PHD2 is ferrous Fe(II) even when purified under
oxygenated conditions,37 arguing against an essential role of
ascorbate in reducing PHD iron. In support of this notion, iron and
2-oxoglutarate have been reported to copurify with 50% and
5%-10% of PHD2, respectively, whereas ascorbate did not copu-
rify at all.37 Recent work by Flashman et al38 showed that ascorbate
does not directly interact with the catalytic domain of PHD2;
however, its intrinsic ene-diol–reducing moiety was found to be
important to promote hydroxylation by PHD2.
GSH fully stimulated in vitro PHD hydroxylation activity only
at rather high concentrations, which is in line with findings reported
previously for N-terminally truncated PHD2.38 The millimolar
GSH concentrations used in our study reflect physiologically
relevant levels of this compound in living cells.39 Moreover, we
found that ascorbic acid is not consumed by coupled substrate
hydroxylation, suggesting that exogenously added GSH does not
simply regenerate potentially copurified oxidized dehydroascor-
bate. Our data rather favor an alternative function of GSH by
preventing oxidative damage to the enzyme itself. Physiologic
concentrations of GSH were able to reduce transition metal- or
peroxide-induced PHD enzyme carbonylation. Despite being gen-
erally referred to as antioxidant, ascorbate, together with oxygen
and transition metals such as Fe(III) or Cu(II), also exerts
pro-oxidative effects by generating hydroxyl radicals in a Fenton-
like reaction.40 Indeed, we found increased PHD2 carbonylation by
ascorbate-iron in vitro, suggesting that GSH might protect PHDs
from the adverse effects of ascorbate. In line with 2 distinct
reaction modes, addition of GSH to hydroxylation reactions
containing saturating ascorbate concentrations markedly increased
the hydroxylation rate of PHDs in vitro. Of note, Co(II) induced
ascorbate depletion, as suggested for cultured cells,28,29 cannot
account for PHD inhibition in our cell-free assays, because we
showed previously that Co(II) only inefficiently catalyses ascorbate
oxidation by air under these assay conditions.16 Direct interference
of Co(II) with the enzymes is supported by the observation that
Co(II) strongly carbonylated purified PHD2 even in the absence of
ascorbate. Moreover, ascorbate and GSH exclusively blunted
Co(II)-induced HIF activation in our cellular models, demonstrat-
ing a complementary function of GSH and ascorbate in oxygen
sensing by living cells. Although simple chelation of Co(II) by
ascorbate and GSH cannot be fully excluded in cell culture
experiments, it should be mentioned that metal chelators naturally
occurring in serum (eg, histidine, glutamic acid, and albumin but
also GSH) are essential to facilitate Co(II)-induced ascorbate
oxidation, because “free” Co(II) is unable to directly oxidize
ascorbate in simple aqueous solutions at neutral pH (for a review,
see Salnikow and Kasprzak28). Thus, the actual redox potential of
the ion in such ternary complexes —rather than the intracellular
concentration of “free” metal—determines its efficacy to act as a
“hypoxia mimetic.”
One of the specific GSH functions is to prevent or reduce
inappropriate disulfide bond formation. Two recent reports identi-
fied PHD2 cysteinyl residues Cys201 and Cys208 to be highly
nucleophilic and surface accessible.32,33 Moreover, crystallographic
analyses predicted that these 2 cysteines might form disulfide
bonds.32,33 Cys201Ser mutation protects recombinant PHD2 from
oxidative damage in vitro and results in a 2.5-fold higher specific
hydroxylation activity. One might speculate that a certain fraction
of wild-type PHD2 enzyme constantly undergoes oxidative modifi-
cation of Cys201, leading to reduced activity. As such, PHD
enzymes could combine oxygen- and redox-sensing properties,
providing a possible explanation for previous work on redox
factors modulating PHD activity.41-43 However, potentiation of
PHD activity by GSH clearly involves mechanisms distinct from
Cys201 oxidation, because both wild-type and Cys201Ser mutated
PHD2 enzymes could be efficiently reactivated from H2O2-induced
damage by GSH.
Translating our biochemical and cellular findings into a sys-
temic context, we did not observe marked alterations in HIF target
gene expression after dietary vitamin C deprivation in Gulo/
mice, providing evidence that other antioxidants might substitute
for vitamin C in vivo. Accordingly, the hypoxic response of
Gulo/ mice with low or undetectable ascorbate in the plasma was
similar to that of mice receiving an ascorbate-supplemented diet.
Consistent with antioxidant redundancy in vivo, a study using the
same animals backcrossed to a BALB/c genetic background found
vitamin C–independent de novo synthesis of collagen in allografted
tumors and unchanged levels of hydroxyproline-collagen. Dermal
hydroxyproline content of collagen was even increased.44 Of note,
treatment of vitamin C–deprived guinea pigs with a cell-permeable
GSH monoethyl ester significantly attenuated the severity of
scurvy-related symptoms, also suggesting a cooperative function of
both antioxidants for P4H function in vivo.45 Moreover, Gulo/
mice have increased levels of total glutathione in brain and liver,
possibly explained by a compensatory mechanism for antioxidative
defense in these animals.46
Interestingly, tumor growth and angiogenesis were retarded in a
syngenic tumor model using vitamin C–deprived Gulo/ mice,
but no changes were observed for HIF-1 protein levels in the
respective tumor tissue.47 The possible value of vitamin C in cancer
therapy recently experienced a renaissance, because it has been
shown that pharmacologic doses of vitamin C decrease growth of
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tumor xenografts in mice by increasing peroxide levels in neoplas-
tic tissue.30,48 Such tumoricidal effects of antioxidants might, at
least partially, involve destabilization of HIF after increased
hydroxylase activity.49,50 Our data support a model of cooperative
function of GSH and vitamin C in regulating the efficiency of PHD
oxygen sensors. Translated to chemotherapy of cancers, combined
treatment with both clinically approved molecules might even
boost their antitumorigenic function.
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Table S1. Sequence of human and mouse primers used for RT-qPCR measurements.  
 
Ca9, carbonic anhydrase IX; Ndrg1, N-myc downstream regulated gene 1; L28, ribosomal 
protein L28; Hif1a, hypoxia inducible factor 1, α subunit; Hif2a, hypoxia inducible factor 2, α 
subunit; Bnip3, BCL2/adenovirus E1B interacting protein 1; Glut1, glucose transporter, member 
1; Pdk1, pyruvate dehydrogenase kinase, isoenzyme 1; Phd1-3, prolyl-4-hydroxylase domain 1-
3; Sod1, superoxide dismutase 1; Sod2, superoxide dismutase 2; Glrx, glutaredoxin; Ednrb, 
endothelin receptor type B; Mmp3, matrix metallopeptidase 3; Svct1, sodium-dependent vitamin 
C transporter 1; Svct2, sodium-dependent vitamin C transporter 2; Epo, erythropoietin; S12, 
Ribosomal protein S12. 
 Species Accession No. Forward primer Reverse primer 
CA9 human NM_001216 5’- gggtgtcatctggactgtgtt -3’ 5’- cttctgtgctgccttctcatc -3’ 
NDRG1 human NM_006096 5’- atgtacccctccatggatca -3’ 5’- tgtggaccacttccacgtta -3’ 
L28 human NM_000991 5’- gcaattccttccgctacaac -3’ 5’- tgttcttgcggatcatgtgt -3’ 
Hif1a mouse NM_010431 5’- ggttccagcagacccagtta -3’ 5’- aggctccttggatgagcttt -3’ 
Hif2a mouse NM_010137 5’- taaagcggcagctggagtat -3’ 5’- actgggaggcatagcactgt -3’ 
Bnip3 mouse NM_009760 5’- gctcccagacaccacaagat -3’ 5’- tgagagtagctgtgcgcttc -3’ 
Ca9 mouse NM_139305 5’- gctgtcccatttggaagaaa -3’ 5’- ggaaggaagcctcaatcgtt -3’ 
Glut1 mouse NM_011400 5’- tctctgtcggcctctttgtt -3’ 5’- gcagaagggcaacaggatac -3’ 
Pdk1 mouse NM_172665 5’- ggcggctttgtgatttgtat -3’ 5’- acctgaatcgggggataaac -3’ 
Phd1 mouse NM_053208 5’- ttgcctgggtagaaggtcac -3’ 5’- gctcgatgttggctaccact -3’ 
Phd2 mouse NM_053207 5’- agccatggttgcttgttacc -3’ 5’- ctcgctcatctgcatcaaaa -3’ 
Phd3 mouse NM_028133 5’- caacttcctcctgtccctca -3’ 5’- ggctggacttcatgtggatt -3’ 
Ndrg1 mouse NM_010884 5’- tcaagatggcagactgtgga -3’ 5’- gttgggggtgatgttgagac -3’ 
Sod1 mouse NM_011434 5’- ccagtgcaggacctcatttt -3’ 5’- cacctttgcccaagtcatct -3’ 
Sod2 mouse NM_013671 5’- ggccaagggagatgttacaa -3’ 5’- gaaccttggactcccaca -3’ 
Glrx mouse NM_053108 5’- aacaacaccagtgcgattca -3’ 5’- atctgcttcagccgagtcat -3’ 
Ednrb mouse NM_007904 5’- cagtcttctgcctggtcctc -3’ 5’- ggactgcttttcctcaaacg -3’ 
Mmp3 mouse NM_010809 5’- ctatacgagggcacgaggag -3’ 5’- ccacccttgagtcaacacct -3’ 
Svct1 mouse NM_011397 5’- tctttggcctcacactaccc -3’ 5’- tcctttttaccatgcccatc -3’ 
Svct2 mouse NM_018824 5’- tgccaggaagggtgtacttc -3’ 5’- ccggtaccaaatatgccatc -3’ 
Epo mouse NM_007942 5’- ggccatagaagtttggcaag -3’ 5’- cctctcccgtgtacagcttc -3’ 
S12 mouse NM_011295 5'- gaagctgccaaagccttaga -3' 5'- aactgcaaccaaccaccttc -3' 
 
 
Table S2. Blood parameters of Gulo-/- mice. All mice received ascorbate free provender for 5 
weeks. Control animals received vitamin C via their drinking water. Heparinized whole blood 
samples were collected from mice kept at ambient oxygen tension or in a hypoxic environment 
(8% oxygen for 24 hours) by cardiac puncture. The values represent mean values ± SD of at least 
three animals per group as indicated. 
20% oxygen [Fi O2] 8% oxygen [Fi O2]  
 +Asc (n=3) -Asc (n=4) +Asc (n=4) -Asc (n=5) 
Hemoglobin(g/dl) 12.57±0.6807 13.43±0.3304 12.33±2.022 12.20±1.030 
 
Hematocrit (%) 40.23±1.528 
 
42.88±0.3862 40.68±6.247 39.72±3.492 
Erythrocytes (106/µl) 
 
8.777±0.5724 9.250±0.09019 8.625±1.275 8.496±0.6687 
Retikulocytes (103/µl) 260.3±42.34 227.0±21.46 295.3±106.4 273.2±53.18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Inhibition of PHDs by MnTMPyP and in vitro hydroxylation activity of 
untagged PHD1-3. (A) Inhibition of PHD1-3 hydroxylation activity by Mn(III) tetrakis (1-
methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP) measured by an in vitro hydroxylation 
assay. The presence of 50 μM MnTMPyP completely abolished hydroxylase activity of all three 
PHDs. Shown are mean values ± SEM of an experiment performed in triplicates. (B) 
Comparison of the purity (upper panels. IB, immunoblotting; Coomassie, protein staining by 
Coomassie blue) and hydroxylation activity (lower panels) of GST-tagged and untagged PHD1-3 
enzyme preparations. Representative experiments performed in duplicates are shown. A 
Gateway-Technology compatible expression vector for GST fusion proteins bearing the 
PreScission protease cleavage site was generated by introducing a Leu-Glu-Val-Leu-Phe-Gln-
Gly-Pro peptide into pDEST20 (Invitrogen) by site-directed mutagenesis. The C201S mutation 
 
 
was introduced into wild-type PHD2 by site-directed mutagenesis. PHD1, PHD2 and PHD3 
expression vectors were generated by homologous recombination with respective Entry vectors 
(Invitrogen). For expression of recombinant proteins, Sf9 cells were infected with baculovirus 
stock and cultured in Grace's insect medium at 27ºC in a humidified incubator for 96-110 hours. 
Cells were collected by centrifugation and lysed in ice-cold 0.1% NP-40, 10 mM Tris-HCl pH 
7.5, 100 mM NaCl, 100 mM glycine and 10 mM DTT. Cleared lysates were incubated with PBS-
equilibrated GSH-sepharose beads (GE Healthcare) for 2 hours at 4°C with gentle agitation. For 
cleavage, beads were washed twice with PBS and equilibrated twice with PreScission cleavage 
buffer (50 mM Tris-Cl pH 7.0, 150 mM NaCl). PreScission protease (GE Healthcare) was added 
to the protein-bound glutathione-sepharose beads (80 U in 960 ml cleavage buffer per 1 ml of 
bead volume) and incubated for 5 hours at 4ºC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. HPLC determination of ascorbate concentrations. (A) Exemplary chromatograms 
derived from samples of blank (60 mM phosphoric acid, left), or spiked standard solutions 
containing 100 μM (middle) and 200 μM (right) ascorbate, respectively. Probes were loaded on a 
Nucleosil C18 column and eluted applying an acetonitrile gradient (0-60%). Arrows indicate the 
position of the peaks specific for ascorbate. (B) Standard curve as obtained after plotting the 
peak areas of ascorbate elutions (given in arbitrary units; AU) against known ascorbate 
concentrations in spiked samples. Regression analysis was performed using Prism 4.0 GraphPad 
software. 
 
 
  
 
 
Figure S3. CoCl2 and H2O2 inhibit the in vitro hydroxylation activity of PHD1-3.  
Dose-dependent inhibition of PHD activity by CoCl2 (upper panel) and H2O2 (lower panel). 
Shown are mean values ± SEM of a representative experiment performed in triplicates. 
 
